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ABSTRACT

Neurodegenerative diseases like Alzheimer’s disease (AD), Parkinson’s
disease (PD), and amyotrophic lateral sclerosis (ALS), include the progressive loss of
structure and function of neurons leading to neuronal death. All of these diseases are
fatal, as there is no cure for them. The causes of these diseases are unknown; however,
there are many proposed mechanisms that lead to neurodegenerative diseases. Oxidative
stress is the leading cause of cell death in neurodegenerative diseases, in addition to other
mechanisms including endoplasmic reticulum stress, proteasome inhibition, nitrosative
stress, inflammation and excitotoxicity. More understanding of the death mechanisms at
work in neurodegeneration is necessary to find ways to block those mechanisms in order
to slow or stop the progress of these disorders. Interest in nutraceutical compounds has
increased recently because of the discovery their bioactive properties. Many studies have
suggested that nutraceutical compounds have the ability to inhibit the different death
pathways.
In this study, we investigated the neuroprotective efficacy of seven natural
compounds in several in vitro models of cell death. In primary cultured rat cerebellar
granule neurons (CGNs), pre-incubation with caffeic acid, which is abundant in green
coffee beans, completely protected against cell death induced by several mechanisms.
Caffeic acid protected against effects of sodium nitroprusside (SNP), an agent that
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induces nitrosative stress, glutamate /glycine which prompts excitotoxicity, hydrogen
peroxide, an inducer of oxidative stress, proteasome inhibitors, 5K medium that induces
caspase-dependent apoptosis, and endoplasmic reticulum stressors. Furthermore, caffeic
acid reduced inflammation induced by lipopolysaccharides in BV2 mouse microglial cell
line. Chlorogenic acid and ferulic acid protected from one agent. Chlorogenic acid only
protected CGNs from SNP; however, ferulic acid protected the CGNs from glutamate
toxicity. Quinic acid did not protect from any agents or stressors. Rosmarinic acid
protected the CGNs against glutamate toxicity, and carnosic acid protected the cells from
5K medium that typically induces apoptosis. Both rosmarinic acid and carnosic acid
protected the cells from SNP and subsequent nitrosative stress. We further suggeste that
carnosic acid protects CGNs from caspase-dependent apoptosis through activation of the
phosphoinositide 3-kinase (PI3K) pro-survival pathway. Pyrroloquinoline quinone (PQQ)
also showed a significant protection against oxidative stress typically induced by
hydrogen peroxide and copper chloride. The cumulative data suggest that nutraceutical
compounds hold promising therapeutic implications for neurodegenerative disease.
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CHAPTER ONE: INTRODUCTION

1.1. Mechanisms of neurodegenerative diseases
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s
disease (PD), and amyotrophic lateral sclerosis (ALS) are progressive nervous system
disorders defined by loss of neurons consequent to multiple factors including, mis-folding
and dysfunctional trafficking of proteins, mitochondrial dysfunction, excitotoxicity, and
oxidative stress (Ferraiuolo et al., 2011; Dawson and Dawson 2003; Chakrabarti and
Mohanakumar, 2016). Neurodegenerative diseases typically target elderly people
between 50-70 years old. While many neurodegenerative movement disorders cause
muscle atrophy, resting tremor, and, postural instability (Thomas and Beal, 2007;
Ferraiuolo et al., 2011), it is also common for many of these disorders to affect patients
mentally by disrupting cognitive function and causing loss memory (Anand et al., 2013).
Nonetheless, the underlying cause and mechanism of neuronal cell death remains largely
unknown. For instance, in the case of ALS, epidemiological studies have revealed that
the disease is caused by a familial mutation in only 5-10 % of patients, while the majority
of patients harbor the sporadic ALS with no known genetic component (Thomas and
Beal, 2007; Ferraiuolo et al., 2011; Anand et al., 2013). It is important to unravel the
1

precise signaling pathways and etiology that underlie fatal neurodegenerative diseases as
only few medications have been approved by US Food and Drug Administration (FDA).
Further, the medications that are currently FDA-approved merely help to decrease the
severity of symptoms but do not cure the underlying cause of the disease (Kumar et al.,
2015). Furthermore, many of these drugs are not very effective, and a number of patients
do not respond to treatment. Although each disease has its own molecular hallmark and
unique etiology, it is intriguing that disruption of similar cellular processes (e.g. oxidative
stress, inflammation, etc.) is believed to be common to several neurodegenerative
diseases. Thus, more efforts must be made to discover drugs that target several common
molecular pathways that underlie these diseases. Further understanding of the
pathological mechanisms contributing to neuronal cell death may be an encouraging
method to identify novel therapeutics for the treatment of these devastating
neurodegenerative disorders.
1.1.1. Apoptosis.
Apoptosis, or programmed cell death (PCD), is a major cell death mechanism.
Apoptosis is characterized by cytoplasmic condensation, nuclear fragmentation, cell
rounding, cytoskeletal collapse, and membrane blebbing (Ghavami et al., 2014).
Disruption of cellular survival and death pathways such as apoptosis are believed to play
a critical role in neurodegenerative diseases. At the cellular level, the caspase family of
proteins are the key executioners in apoptosis (Stroh et al., 2002). There are two types of
caspases: initiator and effector caspases (Ghavami et al., 2014). The initiator caspase
group includes caspase-8 and caspase-9, both of which are activated by upstream signals.
Following activation of caspases-8 and caspases-9, the signal is propagated by activation
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of the downstream effector caspases, caspase-3 and caspase-7 (Los et al., 1995; Fuchs
and Steller, 2011: Ghavami et al., 2009b). External apoptosis is mediated by cell death
molecules like TRAIL, TNFα, and Fas, which activate caspase -8. However, caspase-9 is
activated by internal stress such as starvation and mitochondrial dysfunction (Hashemi et
al., 2013; Los et al., 1995; Fuchs and Steller, 2011). In response to stress, cytochrome c is
released from the mitochondria, causing the formation of the apoptosome complex, or the
caspase-9 activating complex (Fuchs and Steller, 2011). There are two types of apoptotic
pathways; the extrinsic apoptotic pathway and the intrinsic apoptotic pathway (Fig. 1.1).
In the extrinsic pathway, implicated death receptors recruit adaptor molecules to their
death domain, activate caspase-8, and subsequently activate caspase-7 and caspase-3 to
cause cell death. In the intrinsic apoptotic pathway, the imbalance in the level of proapoptotic Bcl-2 family members (Bax, Bak, etc.) and anti-apoptotic members (Bcl-2,
Mcl-1, etc.), results in the formation of Bax/Bak oligomers in the outer mitochondrial
membrane, which forms a pore to release cytochrome c. To enhance our understanding of
the intrinsic apoptosis pathway, primary cultures of cerebellar granule neurons (CGNs)
provide an ideal and commonly used model for this type of study. These cells survive
under high extracellular potassium concentrations, and die by apoptosis when cultured in
a low level of potassium (D’Mello et al., 1993). To study apoptosis, CGNs exposed to
low concentrations of extracellular K + offer a good in vitro model (Lauritzen et al.,
2003) (Fig. 1.2).
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Figure 1.1. Overview of Apoptotic Pathways. The extrinsic and intrinsic pathways
illustrate the binding of the death receptor Fas by the death ligand Fas L, activation
of pro caspases to caspases leading to apoptosis. Cleavage of Bid to t-Bid shows a
conjunction point between the extrinsic and intrinsic pathway where the inhibition
of pro-survival proteins (Bcl2/Bcl-Xl) leads to the activation of Bax and Bak.
Cytochrome c is released from the mitochondria leading to the activation of
caspases and then apoptosis.
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Figure. 1.2. Cerebellar granule neurons (CGNs)-a standard model system in which
to study apoptosis. A. CGN culture was treated with vehicle (control). B. CGN
culture was treated with H2O2.
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1.1.2. Oxidative stress.
Strong scientific evidence suggests that oxidative stress is one of the most
common known mechanisms contributing to degenerative diseases. Oxidative stress is
also thought to contribute to aging, which is one of the highest risk factors for
neurodegenerative diseases. Oxidative stress underlies additional factors that are believed
to lead to neurodegenerative diseases, such as mitochondrial dysfunction and
excitotoxicity (Duffy et al., 2011; Rao and Weiss, 2004).
Free oxygen radicals such as hydroxyl (OH·), superoxide (O2–·) and nitric oxide
(NO·), as well as, other reactive oxygen species (ROS) such as hydrogen peroxide
(H2O2), are produced in our bodies and play an essential role in a variety of critical
biological processes such as gene transcription (Uttara et al., 2009). The production of
ROS is known to be regulated by antioxidants such as glutathione, polyphenols, and
creatine (Uttara et al., 2009). The balance between ROS production and the availability of
antioxidants is critical for determining cell fate, as imbalances between the two results in
oxidative damage to many fundamental molecules (lipid, protein, and DNA), leading to
oxidative stress and potentially cell death (Fridovich, 1999). Current research suggests
that oxidative stress may also arise from genetic mutations. For instance, both oxidative
stress and neuropathology develop in people with hemochromatosis-associated mutations
(Gordeuk et al., 1992). As oxidative stress is one of the most common pathological
mechanisms underlying neurodegenerative disorders, animal models demonstrating key
characteristics of oxidative stress will be useful to find new therapies for these diseases.
For instance, one current model treats animals with toxicants that induce oxidative stress
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(i.e. paraquat) and then observes the effect of this insult. Another approach to modeling
oxidative stress is a genetic one. Transgenic mice that have been manipulated to express
different genes, like super oxide dismutase 1 (SOD1), super oxidative dismutase 2
(SOD2), and glutathione peroxide 1 (GPx1), provide a suitable approach to study
oxidative stress. Moreover, there are a number of genes in Drosophila melanogaster and
Caenorhabditis elegans have been studied to model the biological effects caused by the
production of toxic ROS (Melov, 2002). Each of these model systems is helping to
unravel the contribution of oxidative stress to neurodegenerative disorders.
1.1.3. Inflammation.
Inflammation is a response caused by pathogenic or irritant stimuli that results
in the activation of an organism’s defensive response against that stimulation. Acute
inflammation is inherently protective; however, aberrant inflammation may lead to the
destruction of the host cell. Strong evidence supports a role for neuroinflammation in
various neurodegenerative disorders including AD, PD, and ALS.
Neuroinflammation is a process that includes activation of glia cells, including
microglia and astrocytes. Microglia exert a dual role in the progression of
neurodegenerative diseases, as they have the potential to cause both protection and
degeneration in the central nervous system (CNS). In the short term, microglia have a
major role in the inflammatory process, and protect the CNS integrity; however, when
they are constitutively activated, the morphological characteristics of the cell become
more phagocytic, and display increased levels of the major histocompatibility complex
(MHC) antigens that recognize foreign molecules (Hayes et al., 1987). Microglia also
produce inflammatory cytokines, which are responsible for enhancing the inflammatory
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reaction as a protective measure in neurons exposed to an irritant stimulus. However,
when chronically activated microglia may cause toxicity to neurons. This type of toxicity
in the CNS is a pathogenic hallmark of several neurodegenerative disorders, and is
initiated by the production of inflammatory cytokines like IL-1β, TNF-α, and IL-6 (Glass
et al., 2010). Furthermore, activated microglia can also engulf intact cells, leading to
neurodegeneration (Glass et al., 2010). Studying the mechanism of neuro-inflammation is
a critical way to modulate many chronic neurodegenerative disorders linked to this
mechanism. There are different types of models to study neuro-inflammation including
viral, drug administration, and genetic models. There are three genetic mouse models of
Alzheimer’s diseases that are known to cause microgliosis and astrogliosis (activated
microglia and astrocytes, respectively). These models include APP/PS1, P301S, Tau, and
Tg2576. Another model of neuro-inflammation is AVV-α-synuclein a common viral
model of Parkinson’s disease. Administration to mice of the neurotoxin MPTP, is another
model of Parkinson’s disease used to study the neuro-inflammatory phenotype of this
disease (Jackson-Lewis and Przedborski, 2007). Lipopolysaccharide administered to
animals or cultured cells provides another technique to study neuro-inflammation in vitro
(Lee et al., 2008; Gui et al., 2012).
1.1.4. Excitotoxicity.
Excitotoxicity plays a substantial role in many human diseases such as
ischemia, trauma, and neurodegenerative disease (Doble, 1999). Excitotoxicity is defined
as an extreme stimulation of glutamatergic receptors by the excitatory amino acid
neurotransmitter, glutamic acid. Aberrant stimulation of glutamatergic receptors leads to
enhanced intracellular calcium elevation (Doble, 1999). As a result of overstimulation of
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glutamate receptors due to either elevated synaptic levels of glutamate or increased
sensitivity of the postsynaptic neuron to glutamate, excitotoxicity can trigger neuronal
cell death (Van Damme et al., 2005).
Regulation of neuronal glutamate uptake is tightly controlled by a variety of
diverse mechanisms, which may be implicated in excitotoxicity when glutamate levels
are dysregulated. For instance, glutamate undergoes reuptake from the synapse by
glutamate transporter, excitatory amino acid transporter 2 (EAAT2) (Ferraiuolo et al.,
2011). In addition, α – Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors are also implicated in glutamate excitotoxicity, as they are responsible for much
of the glutamatergic neurotransmission in the CNS. The permeability of AMPA
receptors to calcium is dependent on its GluR2 subunit (Williams et al., 1997), and low
expression of GluR2 leads to increase Ca 2+ influx and neuronal toxicity (Ferraiuolo et
al., 2011). N-Methyl-D-aspartate (NMDA) is another glutamate receptor that is believed
to contribute to both excitotoxicity and thus, neurodegenerative diseases (Zhou et al.,
2013). When NMDA receptors are over activated, excessive neuronal Ca 2+ influx can
lead to enhanced excitotoxicity and subsequent neuronal cell death (Zhou et al., 2013).
Given the role of glutamate in regulating neuronal Ca 2+ influx, it is not surprising
that glutamate excitotoxicity is associated with many other pathways thar have been
implicated in contributing to the etiology of neurodegenerative disorders. For instance,
excitotoxicity has been intimately linked to mitochondrial dysfunction, the production of
toxic ROS and reactive nitrogen species (RNS), loss of mitochondrial membrane
potential, and apoptotic cell death (Prentice et al 2015; Didier et al., 1996; Finiels et al.,
1995).
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In order to understand the contribution of excitotoxicity to neurodegeneration,
several suitable models to study this phenomenon have been designed, such as the lurcher
mouse. These transgenic mice possess a mutation in an excitatory amino acid receptor
delta2 (GluRdelta2) that causes excitotoxicity and is a relevant model for excitotoxicity
cell death (Philips, 1960). However, more work is needed to test the specific
involvement of excitotoxicity in the pathogenesis of various neurodegenerative disorders.
Further, since this mechanism is implicated in various other pathological pathways, it is
important to develop drugs that block excitotoxicity in order to develop promising
therapeutics for the treatment neurodegenerative diseases. Interestingly, the only drug
that is currently approved by the FDA for the treatment of ALS, riluzole, targets
glutamatergic receptors. However, riluzole only extends the survival of ALS patients a
mere three months on average (Zoccolella et al., 2007), underscoring the need to
precisely delineate the involvement of excitotoxicity in the progression of various
neurodegenerative diseases such as ALS.

1.1.5. Reactive nitrogen species
Another possible factor underlining the etiology of neurodegenerative diseases
is the overproduction of reactive nitrogen species (RNS). For example, the generation of
nitric oxide may accumulate as a consequence of excessive activation of the
glutamatergic receptor that increases the entry neuronal Ca 2+ levels. In turn, this leads to
the activation of neuronal NO synthase (nNOS) (Garthwaite et al., 1988; Bredt et al.,
1991). In addition to the generation of nNOS, mitochondria have a well-described role in
generating free radicals during respiration, such as super-oxide anion, which reacts with
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nitric oxide to form the toxic product peroxynitrite (Beckman et al., 1990; Lipton et al.,
1993). Nitrosative stress has also been demonstrated to contribute to the misfolding of
proteins, which is has been described in many neurodegenerative diseases (Nakamura and
Lipton, 2007). Yu and Chuang (1997) established that treatment with sodium
nitroprusside (SNP), a nitric oxide donor (NO), is suitable model to generate nitrosative
stress in vitro. Thus, treating cell cultures with specific concentration of SNP is a wellestablished model to study nitrosative stress and to understand the pharmacological
pathways regulating RNS-induced neuronal death.
1.1.6. Endoplasmic reticulum stress
The endoplasmic reticulum (ER) is an essential organelle responsible for
many cellular processes including the synthesis, folding, modification, and transport of
proteins (Paschen and Frandsen, 2001; Breckenridge et al., 2003; Rao et al., 2004).
Nevertheless, under some genetic and environmental conditions, ER stress can lead to
activation of the unfolded protein response (UPR). It is well documented that activation
of the UPR can enhance aggregation of misfolded proteins, and subsequently promote
cell death (Lindholm at el., 2006). The involvement of the UPR to the progression of
neurodegenerative diseases had been studied in a variety of contexts (Scheper et al.,
2015), and one mechanism by which ER stress may contribute to neuronal cell death is
through activation of mitochondrial apoptosis (Lindholm et al., 2006). Given this
important involvement of ER stress is maintaining cellular survival, it is not surprising
that dysregulation of the UPR is one of the mechanisms that scientists are investigating as
a promising target for such diseases.
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To study ER stress, Iwawaki et al. (2004) established the ER stress-activated
indicator (ERAI) in living cells. In addition, ER stress may also be studied in vitro by
using different insults like tunicamycin, thapsigargin, and Brefedin A, depending on the
type of the cell culture. In future studies, these tools will be important for elucidating the
specific involvement of ER stress in neuronal cell death.
1.1.7.

Proteasome dysfunction.
Every cellular system survives by maintaining a balance between the production

and the degradation of proteins, which determines on the lifespan of the protein. The
proteasome is a multi-subunit enzyme that plays a fundamental role in protein
degradation by degrading all abnormal proteins and expired proteins (Tanaka et al.,
2014). However, dysfunctional proteasomes can lead to protein mis-folding and
aggregation of abnormally modified proteins, thereby promoting in cell death. MG132
(carbobenzoxy-Leu-Leu-Ieucinal) is one tool used to study proteasome inhibition. This
aldehyde can block proteasome activity, causing the cell to switch to other mechanisms
that play a role in neurodegenerative disorders, including apoptosis and mitochondrial
dysfunction (Wu et al., 2002; Ling et al., 2003; Qiu et al., 2000). In addition, there are
several animal models to study proteasome inhibition through ablation of particular
proteasome subunits, such as deletion of all of the β1i, β2i, and β5i subunits (Kincaid et
al., 2012). Moreover, deletion of the thymo-proteasome subunit β5t provides an
additional model of proteasome dysfunction (Murata et al., 2007).
Modulation of each of the mechanisms discussed above offers promising
approaches to identify novel molecular pathways as targets the therapeutic treatment of
devastating neurodegenerative diseases with no known cause (Fig. 1.3).
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Figure. 1.3. Overview of the common pathogenic mechanisms of neurodegenerative
diseases. Neuron death is the main cause of neurodegenerative diseases. Many
mechanisms contribute to neuron death including activated astrocytes and
microglia, oxidative stress, mitochondrial dysfunction, excitotoxicity, proteasome
inhibition, and endoplasmic reticulum stress.
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1.2. Nutraceutical compounds
After many clinical studies failed aimed to treat neurodegenerative disorders,
with the long duration necessary to approve new drugs, and the increasing number of
patients with neurodegenerative disorders, scientists have begun to investigate novel
therapeutics for these diseases based on the underlying disease mechanisms. New
pathways of exploration include patient lifestyle choices and a new examination of
traditional and/or holistic therapies that may modulate the several of the common
molecular pathways implicated in these disorders. In particular, oxidative stress and
neuro-inflammation are two specific pathways which are implicated in several distinct
diseases including PD, AD, and ALS. To block these pathways, scientists are beginning
to study natural compounds (nutraceuticals) with antioxidant and anti-inflammatory
properties.
Since many nutraceuticals are not regulated by the FDA, they are not subject to
the same regulatory hurdles as pharmaceutical drugs. The term “nutraceutical” is created
from two root words; nutrition and pharmaceutical. This term was originally coined by
Stephen De Felice, the chairman of the Foundation for Innovation in Medicine (FIM),
Cranford NJ in 1989 (Maddi et al., 2007; Brower 1998). According to Dr. Felice, the
nutraceuticals cover any food or part of a food that possess healthy properties which can
provide benefit against diseases. Nutraceuticals can be extracted as a product of food, and
can be taken as a powder or supplement (Wildman, 2001; Bull, 2000). Many studies have
investigated the medical benefits of a number of nutraceuticals, including those against
cold and cough, sleeping disorders, cancer, depression, diabetes, and various
neurodegenerative diseases (Pandey et al. 2010; Bhullar and Rupasinghe, 2013). In
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addition to the bioactivities of nutraceutical compounds, many studies indicate that some
of these compounds have the ability to cross the blood brain barrier and gain access to
specific regions of the brain to provide beneficial effects (Choi et al., 2012). Thus, there
is great interest in identifing new nutraceutical compounds with therapeutic effects for the
treatment of neurodegenerative diseases. One class of these compounds that has gained
significant attention is polyphenols.
1.2.1. Polyphenols.
Polyphenols are compounds produced as secondary metabolites, and are found
in many plants, fruits, vegetables spices, oils, herbals, teas, and wine (Fig.1.4). These
compounds possess significant antioxidant properties through their ability to either
scavenge free radical species or increase the levels of antioxidants in organisms (Choi et
al., 2012). The neuroprotective effect of polyphenols is due to their intrinsic antioxidant
activity and their ability to enhance the capacity of endogenous cellular antioxidant
molecules via activation of the Nrf2/ARE pathway. In turn, Nrf2 activates and modulates
many antioxidants like γ-glutamylcysteine ligase, the rate-limiting enzyme for
glutathione synthesis and an essential antioxidant compound (Dumont and Beal, 2011;
Moskaug et al., 2005). In addition to the antioxidant properties of polyphenols, many in
vitro studies have identified polyphenols as important modulators of other cellular
process such as apoptosis, gene expression, and intracellular signaling (Duthie et al.,
2003).
Anti-inflammatory activities of polyphenols have also been reported (González et
al., 2011), therefore increasing insight into their ability to reduce the risk of many agerelated disorders, such as neurodegenerative disorders. Many studies demonstrate that the
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anti-inflammatory effects of polyphenolic compounds lead to a reduction the production
or the level of many cytokines and transcription factors which are related to the
inflammation process. For example, one in vivo study found that polyphenolic
compounds can suppress multiple inflammatory biomarkers (Parelman et al., 2012).
Moreover, diets containing fruits that are rich in polyphenols have been shown to reduce
the level of Interleukin 6 (IL-6), a major pro-inflammatory cytokine (Joseph et al., 2016).
In addition, nitric oxide (NO), one of the inflammatory mediators, is reduced by several
different polyphenolic compounds (Soliman and Mazzio, 1998).
An additional inflammatory marker shown to be modulated by polyphenols is the
nuclear transcription factor (NF-κB). Under normal conditions, this transcription factor is
found in the cytoplasm, but once activated by free radicals or inflammation, it
translocates to nuclei and induces transcription of many genes involved in cellular
process such as inflammation (Butcher and Denkers 2002). Different polyphenolic
compounds have been shown to significantly inhibit the activity of NF-κB transcription
factor. Several studies suggest that a diet comprised of a high intake of polyphenol-rich
foods improves cognitive performance in elderly people and reduces risk of dementia
(Nurk et al., 2010; Polidori et al., 2009; Hughes et al., 2010; Morris et al., 2006). It has
been reported that elderly people who are at the highest risk for degenerative disorders,
demonstrate decreases in important antioxidants, which leads to the accumulation of
ROS, an underlying pathophysiologic mechanism that many contribute to the onset or
progression of neurodegenerative diseases. Thus, polyphenolic rich diets are one
promising area being investigated as a mechanism to reduce neurodegeneration.
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Figure. 1. 4. Common polyphenols and their natural sources. A. Chemical structure
of chlorogenic acid and one of its major sources, green coffee beans. B. Chemical
structure of rosmarinic acid and rosemary herb, one of its main sources. C.
Chemical structure of pyrroloquinoline quinone (PQQ) and one of its major sources
green tea.
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1.2.1.1 Coffee
Coffee is the second most consumed drink in the world (Bae et al., 2014).
Coffee contains different chemicals including caffeine, carbohydrates, lipids, vitamins,
minerals, alkaloids, and polyphenols (Spiller, 1984). Many studies have demonstrated
that coffee intake may have pharmacological benefits for the treatment of several chronic
diseases. For example, in a study examining the effect of coffee on type 2 diabetes, coffee
intake significantly reduced the risk of type 2 diabetes in women (Van Dam et al., 2006).
Moreover, coffee consumption was demonstrated to decrease the risk of liver disease by
controlling the level of enzymes that are well known to elevate liver damage (Homan and
Mobarhan 2006). Coffee consumption has also been shown to reduce the risk of different
type of cancer (Cano-Marquina et al., 2013). Finally, coffee intake has been demonstrated
to mitigate the development of neurodegenerative diseases. Indeed, two studies
demonstrated that drinking coffee on a regular basis lowered the risk of developing either
Parkinson’s disease or Alzheimer’s diseases (Trevitt et al., 2009; De Mendonca et al.,
2010).
One the major polyphenolic component in coffee is chlorogenic acid (Figure.
1.5) (Sato et al., 2011; Upadhyay and Mohan Rao, 2013). Chlorogenic acid is formed by
the esterification of cinnamic acids, such as caffeic acid and ferulic acid, with quinic acid
(Fang et al., 2016). The benefits of chlorogenic acid are attributed to several biological
effects, such as anti-inflammatory and antioxidants activities (Shi et al., 2016). The
antioxidant activity of cholorgenic acid is related to its chemical structure, which contains
a phenolic hydroxyl group known to scavenge both the hydroxyl radical and superoxide
anion radical (Bohn et al., 2014; Gallus et al., 2002; Padol and Hunt, 2004; Phan et al.,
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2003). Chlorogenic acid can also increase the expression of nuclear Nrf2, which is a
known transcriptional regulator of many pro-survival antioxidant genes (Shi et al., 2016).
Furthermore, chlorogenic acid suppresses the NF-kB-dependent transcription of proinflammatory signaling pathway components and reduces the expression of proinflammatory genes, including cytokines, chemokines, and adhesion molecules (Shen et
al., 2012). In addition, chlorogenic acid also has been reported to exhibit significant prosurvival biological activities including anti-carcinogenic (Rakshit et al., 2010), antiobesity (Cho et al., 2010), anti-microbial (Lou et al., 2011), anti-tumor (Granado-Serrano
et al., 2007), anti-lipidemic activity, and anti-diabetic effects (Ong et al., 2013). Recent
research indicates that chlorogenic acid may also inhibit the activity of HIV-1 RNase
(Naso et al., 2014). In an in vivo study, chlorogenic acid reduced infarct volume and
rescued sensory motor function in a rat model of transient middle cerebral artery
occlusion (Lee et al., 2012). Chlorogenic acid has been suggested to reduce the risk of
many health issues like type 2 diabetes and cardiovascular disease (Ranheim and
Halvorsen 2005; Salazar-Martinez et al., 2004).
Many findings indicate a promising effect of chlorogenic acid on neuronal
survival. For instance, chlorogenic acid directly protects neurons in vitro from
cytotoxicity and death that are induced by glutamate, perhaps by controlling the entry of
Ca 2+ influx (Mikami and Yamazawa 2015). New evidence has also supported the
positive effects of chlorogenic acid on the progression of specific neurodegenerative
disorders, such as AD. In the Oboh et al. (2013) study, the authors demonstrated that
chlorogenic acid inhibits acetylcholinesterase (AChE) and butyrylcholinesterase (BChE),
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the key enzymes associated with the development of AD. Thus, chlorogenic acid is a
nutraceutical with significant promise for neurodegenerative disease therapy.
More recently, a growing interest examining the pharmaceutical effects of the
cholorgenic acid-derivative, caffeic acid, is emerging. Caffeic acid is a polyphenol
compound that is abundant in many agriculture products such as fruits, vegetables, teas,
and coffee (Moridani et al., 2001; Scalbert et al., 2005). Caffeic acid has a wide variety of
health benefits including anti-inflammatory, anti-cancer, anti-thrombosis, antihypertensive, anti-fibrosis, anti-viral, anti-oxidative, and anti-tumor properties (Touaibia
et al., 2011; Rehman and Sultana, 2011; Roos et al., 2011; Scapagnini et al., 2011). A
study on human peripheral blood mononuclear cells showed that cells pretreated with
caffeic acid, and subsequently exposed to H2O2, are protected from the apoptotic damage
that is induced by this ROS-inducing compound. The authors further demonstrated that
the protection against ROS may have been afforded by the free radical scavenging
properties of caffeic acid. Moreover, this study demonstrated that caffeic acid inhibits
lipid peroxidation and protects DNA from oxidative damage (Khanduja et al., 2006).
Caffeic acid also has been shown to have promising effects in animal models of
AD. In one study, Kim et al. (2015) found that administration of caffeic acid to mice
injected with Aβ25-35 peptide protected against both Aβ toxicity and oxidative stress,
which are two of the most common hallmarks of AD (Kim et al., 2015). In the methyl-4phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of PD, several inflammatory
factors are induced including interleukin (IL)-1beta, IL-6, and tumor necrosis factor
(TNF)-alpha. However, administration of caffeic acid to mice inhibited pro-inflammatory
the effect of MPTP treatment (Tsai et al., 2011). Caffeic acid was also demonstrated to
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prevent neurotoxicity induced by acrolein in vitro. This insult has the ability to mimic
many mechanisms that underlie neurodegenerative pathways, such as those activated in
AD. Indeed, pretreating cells with caffeic acid decreased neurotoxicity, ROS, and also
preserved the essential endogenous antioxidant, glutathione (Huang e al., 2013). Thus,
similar to chlorogenic acid, caffeic acid is neuroprotective in multiple models of neuronal
toxicity and neurodegeneration.
Ferulic acid is another polyphenol compound found in coffee that is also a
chlorogenic acid derivative. Recently, scientists have focused their attention on the
potential of ferulic acid to treat many disorders given its anti-oxidant activity and antiinflammatory activities. Ferulic acid modulates many anti-oxidant enzymes, such as
superoxide dismutase (SOD), catalase (CAT), as well as the chaperone heat shock protein
(Hsp)-70 (Mancuso and Santangelo, 2014). Ferulic acid also has the ability to scavenge
free radicals, and it is a promising therapy for various diseases that depend on the
downregulation of NF-kB and enhancing the expression of antioxidant enzymes, such as
cancer, cardiovascular diseases, and diabetes, (Mancuso and Santangelo, 2014).
The pharmacological activities of ferulic acid also suggest that it may be a novel
therapy for neurodegenerative diseases, such as AD. In a transgenic mouse line fused
with Aβ peptise, pretreatment with ferulic acid considerably reduced memory loss and
decreased the level of neuro-inflammation, reactive gliosis, and interleukin 1 beta (IL1B) production (Yan et al., 2001). Further, a study by Cho et al. (2005) demonstrated that
long-term administration of ferulic acid reduced astrocyte activation induced by hamyloid peptide (1–42) in vivo. Higher doses of ferulic acid led to greater reductions of
the inflammation bio-markers in vivo (Jin et al., 2005), and ferulic acid was also shown to
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attenuate the microglia activated by LPS in a rat model of chronic neuro-inflammation
(Wenk et al., 2004). Moreover, in a similar manner, an in vitro study showed that ferulic
acid reduces several biomarkers of inflammation that are induced by LPS (Sakai et al.
1997).
Quinic acid is another chlorogenic acid metabolite, yet unlike caffeic acid and
ferulic acid, quinic acid does not possess a phenolic hydroxyl group. Interestingly, the
phenolic hydroxyl group is the main structural basis for the antioxidant properties of
these compounds (Pandey and Rizvi 2009). Thus, perhaps it is not surprising that there
are not currently many studies examining the neuroprotective effects of quinic acid.
Nonetheless, limited evidence has demonstrated that quinic acid reduces NF-KB
activation and displays anti-viral effects in vitro (Akesson et al., 2005; Wang et al.,
2009).
Further, several studies described the bioactivities of quinic acid derivatives: 5-Otrans-o-coumaroylquinic acid methyl ester, chlorogenic acid methyl ester, 4, 5-dicaffeoyl
quinic, and macranthoin G (Hur et al., 2001). 4,5-dicaffeoyl quinic acid, one of its
derivatives showed a significant neuroprotective effect against Aβ- induced toxicity in
vitro (Hur et al., 2001). (2)3, 5-dicaffeoyl-muco-quinic acid, another derivative has the
ability to enhance neurite outgrowth of PC12 cells (Hur et al., 2001). Thus, despite
evidence demonstrating that quinic acid may be able to modulate neuronal survival,
studies do not suggest that quinic acid mediates neuronal survival through significant
antioxidant and/or anti-inflammatory properties, as do other chlorogenic acid metabolites
containing a phenolic hydroxyl group.
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Figure. 1. 5. Chemical structure of chlorogenic acid and its three major metabolites.
A. Chemical structure of chlorogenic acid. B. Chemical structure of caffeic acid. C.
Chemical structure of ferulic acid. D. Chemical structure of quinic acid.
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1.2.3. Rosemary.
Medical plants have been used as a major source of various pharmacological
agents for many decades. Rosemary is a Mediterranean herb that is considered a
traditional therapy for many health conditions such as rheumatic diseases (Bellumori et
al., 2015). Many studies have shown numerous bioactivities of rosemary extract
including antioxidant, free radical scavenging, anti-inflammatory, antimicrobial,
antipyretic, and antidiabetic properties (Erkan et al., 2008; Basaga et al., 1997; Arranz et
al., 2015; Laham et al., 2013; Al attar and Shawush, 2015; Bakirel et al., 2008). All of
these activities may be related to its major polyphenol components, which are carnosic
acid and rosmarininc acid (Ribeiro et al., 2016) (Fig. 1.6). Rosmarinic acid, one of the
major rosemary polyphenol constituents, has been reported in several studies to possess
several pharmaceutical properties like anti-inflammatory, anti-oxidant, antitumor, antiviral, and antimicrobial effects (Bulgakov et al. 2012; Wu and Wang, 2012).
The promising properties of rosmarinsic acid prompted scientists to
investigate the effect of this compound on human health disorders including, AD
(Vladimir-Knezevic et al., 2014), cardiovascular disease (Karthik et al. 2011), and
allergic inflammation (Sanbongi et al. 2004). Rosemary extract produced a dramatic
inhibition of astrogliosis in a rat model of repetitive mild traumatic brain injury by
decreasing the levels of the neuroinflammatory biomarkers, IL-1β, IL-6, and TNF-α
(Song et al., 2016). The protective effects of rosmarinic acid have also been investigated
in a mouse model of ALS. Administration of rosmarinic acid to ALS mice expressing a
mutant SOD1 transgene, increased the life span, improved spinal cord morphology,
prevented body weight loss, and increased motor performance (Shimojo et al., 2010).
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Rosmarinic acid has also been demonstrated to protect skin cells from the exposure of
solar ultra-violet radiation based on its antioxidant and anti-inflammatory activities (Kim
et al., 2015). The anti-tumor effect of rosmarininc acid established in the Kim et al.
(2015) study was based on the compound enhancing TNF-α-induced-apoptosis in human
leukemia U937 cells. The antioxidant effects of rosmarinic acid were mediated via its
free radical scavenging and this led to its protection from oxidative stress (Perez-Fons et
al., 2010). Suppression of ROS, intracellular glutathione depletion, and suppressing
different inflammatory cytokines has been demonstrated by treating human cells with
rosmarinic acid (Zdarilova et al., 2009). Altogether, increasing evidence suggests that
rosmarininc acid suppresses many pathways that contribute to neurodegenerative
diseases.
Carnosic acid is another polyphenolic compound abundant in rosemary
(Rosmarinus officinalis L.), and it has been proposed that the majority of the antioxidant
activity of rosemary extract may be attributed to carnosic acid (Aruoma et al., 1992). The
chemical structure of carnosic acid captured the attention of researchers due to its
similarity to caffeic acid. Intriguingly, carnosic acid contains the same phenolic hydroxyl
group that is proposed to contribute to oxygen radical scavenging activity (Nakamura et
al., 2003). Numerous health benefits have been observed with carnosic acid such as, antioxidant, anti-inflammatory, anti-carcinogenic, and anti-obesity (Hadad and Levy, 2012;
Yesil-Celiktas e al., 2010; Park and Sungb, 2015). Furthermore, carnosic acid enhances
the expression of many detoxifying enzymes like glutathione S-transferase (GST) and
NADH-quinone oxidoreductase 1 (NQO1) (Debersac et al., 2001). The stimulation of
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these types of enzymes may contribute to the ability of carnosic acid to protect cells from
ROS and RNS, for instance, in RAW264.7 macrophages (Xiang et al., 2012).
Several studies suggest different intracellular mechanisms to explain the
neuroprotective effects of carnosic acid, and many of these mechanisms implicate
modulation of the Nrf2 pathway. In this scenario, carnosic acid binds to Keap1, the
suppressor of Nrf2, and the latter translocates from the cytoplasm to the nucleus to bind
the ARE of various genes. Lastly, the induction of transcription of phase 2 enzymes is
activated due to the previous binding (Satoh et al., 2008). The anti-viral properties of
carnosic acid have also been demonstrated in a study by Shin et al., (2013), which
demonstrated that human respiratory syncytial virus (hRSV) replication and infection is
inhibited in vitro by treatment of human adenocarcinoma alveolar basal epithelial cell
line A549 cells with carnosic acid. Further, in an in vivo study, carnosic acid showed an
anti-inflammatory action by inhibiting the cytokines, cycloxygenase-2 (COX-2), IL-1β,
and TNF-α, which are known to mediate responses to inflammation in different cells
(Mengoni et al., 2011).
The neuroprotective effects of carnosic acid have also been examined in different
disease models, both in vitro and in vivo. In a PD study, the authors demonstrated that
pretreatment of either SH-SY5Y neuroblastoma cells or a rat model of PD with carnosic
acid, protected against 6-hydroxydopamine (6-OHDA)-induced toxicity. The protection
observed was related to the anti-antioxidant activity of carnosic acid through its ability to
increase protein expression of ɣ-glutamateyl-cysteine ligase catalytic subunit, ɣglutamyl-cysteine ligase modifier subunit, superoxide dismutase, and glutathione
reductase. Further, the anti-apoptotic properties of carnosic acid were also observed,
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such as blocking the reduction of Bcl-2/Bax ratio and inhibiting 6-OHDA-induced
caspase-3 cleavage (Wu et al., 2015). In an in vitro model of AD-related toxicity, it was
demonstrated that carnosic acid protects cells from Aβ-induced apoptosis (Meng et al.,
2015). Thus, many lines of evidence suggest that carnosic acid may be beneficial for the
treatment of neurodegenerative diseases caused, in part, by the production of toxic ROS
and/or apoptosis, such as PD and AD.
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Image credit: http://www.health-ingredients.com/cosmetic-ingredients/rosemaryextract.html

Figure. 1. 6. Chemical structure of major compounds in rosemary. A. Chemical
structure of rosmarinic acid. B. Chemical structure of carnosic acid.
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1.2.4. Pyrroloquinoline quinone
Pyrroloquinoline quinone (PQQ) is a bioactive compound that is found naturally
in various foods, but with particularly high concentrations in fermented soy beans, green
tea, kiwi, green peppers, and papaya (Kumazawa et al., 1995) (Fig. 1.7). Recently, PQQ
has received attention due to its multiple bioactivities including antioxidant, antiinflammatory, anti-diabetic and anti-cancer properties (Yang et al., 2014; Harris et al.,
2013; Akagawa et al., 2015; Min et al., 2014). However, it is distinguished from the
previous compounds discussed in this thesis by its ability to stimulate mitochondrial
biogenesis (Stites et al., 2006). PQQ also influences many essential physiological
processes in the cell, which were demonstrated in in vivo nutritional studies where mice
were given a diet lacking in PQQ. PQQ-deficient mice showed attenuated in growth,
immune response, and reproductive performance (Akagawa et al., 2015). Also, a PQQdeficient diet was shown to lead to reduced mitochondrial quantity, and deficiencies in
both lipid and energy metabolism in rats (Bauerly et al., 2011). Human studies have also
demonstrated that dietary PQQ is essential for maintaining endogenous antioxidant levels
and diminishing pro-inflammatory mediators (Harris et al., 2013). Furthermore, PQQ
showed a substantial neuroprotective effect in multiple in vivo and in vitro studies.
Pretreatment with PQQ prior to exposure to various oxidative stressors, demonstrated a
noteworthy neuroprotection in SH-SY5Y neurolastoma cells (Hara et al., 2007; Nunome
et al., 2008). A similar protective effect was observed in vivo in rats with dietary PQQ.
Addition of PQQ to the diet markedly improved learning ability when compared
to control rats (Ohwada et al., 2008).
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The protection afforded by PQQ occurs primarily through modulation of the NFKB pathway, resulting in the suppresion of numerous inflammatory mediators like TNFα, iNOS, and IL-1β, that are enhanced in vivo and in vitro by LPS treatment (Yang et al.,
2014). The mechanism underlying the neuroprotective effects of PQQ against glutamateinduced cell death have also been investigated. PQQ protects neurons from excitotoxicity
in a PI3K/Akt-dependent manner that leads to stimulation of Nrf2 and regulation of
antioxidant genes (Zhang et al., 2012). Another protection pathway activated by PQQ
has been demonstrated by Yang et al. (2015), and involves control of the mitochondria
pathway. In their study, PQQ induced the expression of pro-survival Bcl-2, and also
decreased the Bax-dependent release of mitochondrial cytochrome c, therefore inhibiting
apoptosis. As we mentioned above, PQQ also stimulates mitochondrial biogenesis, which
was demonstrated by Chowanadisai et al. (2010) to occur through phosphorylation of
cAMP response element-binding protein (CREB), the regulator of peroxisome
proliferator-activated receptor-ɣ coactivator-1α (PGC-1 α). The latter, in turn, induces
mitochondrial biogenesis by activating nuclear respiratory factors. One important point is
that PQQ showed a remarkable protective effect against diverse mitochondrial inhibitors
(Chowanadisai et al., 2010). Thus, PQQ is a potential therapy for many diseases that are
caused by mitochondrial deficiency, such as PD, which is often referred to as a
mitochondrial disorder. In this context, Zhang et al. (2014) studied the signaling
pathways that are involved in the protective effects of PQQ against a PD model in vitro,
elucidating a role for PQQ protecting against rotenone- induced injury via modulation of
the expression of Bcl-2 and Bax, and by activation of the pro-survival ERK1/2 pathway.
In another in vitro model based on the aggregation and amyloid fibril formation pathway
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implicated in AD and PD, PQQ decreased both mechanisms and reduced cytotoxicity
(Kim et al., 2010). It has also been suggested that PQQ is a promising therapy for AD and
dementia. It is thought that reducing the expression of nerve growth factor (NGF) may
contribute to AD and PD through hindrance of cholinergic neuron survival. Pretreatment
with PQQ induced the level of NGF in vivo and in vitro (Yamaguchi et al., 1993).
The neuroprotective effects of PQQ have been further investigated in diverse
models of neurological disorders. Significant improvement in the recovery from
traumatic brain injury in rats was observed with treatment of PQQ (Zhang et al., 2012). In
addition, β-amyloid aggregation is one of the pathological hallmarks of AD and is a cause
of apoptosis. Interestingly, PQQ significantly protects human neuroblastoma SH-SY5Y
cells from death induced by β 25-35 peptide through modulation of Bcl-2, Bax, and
caspase-3 (Zhang et al., 2009). In another study, a dramatic reduction in infarct size from
focal cerebral ischemia, and improved behavior, have been demonstrated in rats after
pretreatment or co-treatment with PQQ (Zhang et al., 2006). This neuroprotective
compound may also have relevance as a potential therapy for stroke as a significant
reduction of infarct size was demonstrated following PQQ treatment in an in vivo model
of cerebral hypoxia/ischemia (Jensen et al., 1994). In summary, PQQ protects from
several death pathways in neurons through not only antioxidant and anti-inflammatory
effects, but also through its capacity to modulate mitochondrial biogenesis, intrinsic
apoptosis, and growth factor signaling.
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Image credit:
https://www.researchgate.net/publication/264799310_Discovery_of_a_
Eukaryotic_Pyrroloquinoline_Quinone

Figure. 1.7. Chemical structure of pyrroloquinoline quinone (PQQ).
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1.3. Models to study neuronal cell death and neuroinflammation
1.3.1. Cerebellar granule neurons (CGNs)
Finding a good model to study the molecular and cellular mechanisms of
neurodegenerative diseases was a major challenge for scientists for decades. Primary
cultures of cerebellar granule neurons (CGNs) have been recognized to be a standard
model to study various fields of development, function, and neurobiology in vitro. While
numerous studies have utilized various cells to study the pathways of neuronal cell death,
CGNs have been proposed as the most reliable in vitro model to study survival and
apoptotic pathway implicated in neuroprotection and neurodegeneration. One of the
remarkable characteristics of this primary cell culture system is that some of the
conditions and pathways that control neuronal survival and apoptosis in vivo can also be
stimulated in culture in CGNs (Contestabile 2002). This is a very important component of
properly investigating the neuroprotective effects of drugs or natural compounds as it
allows for the design of appropriate experiments and manipulations of the cell death
pathways.
Multiple molecular pathways that are implicated in neurodegenerative diseases
were originally investigated utilizing CGNs as a model to study apoptosis the capacity of
small molecules to reverse these effects. For example, ROS-induced cell death is one of
the most common death pathways implicated in neurodegenerative diseases that was
initially characterized in in vitro CGNs cultures (Behl et al., 2000). As expected, the
apoptotic death induced by ROS in CGNs can been reversed by using antioxidants and
free radical scavenging compounds (Contestabile, 2001). In addition to ROS-induced cell
death, excessive glutamate exposure and proteasome inhibition have also been
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characterized in CGNs (Dessi et al., 1994; Canu et al., 2000). ER stress and nitrosative
stress also induce neuronal death, and have also been tested in CGNs have been usedto
understand more about the pathological pathways in degenerative diseases and to find
some way to manipulate them pharmacologically (Kosuge et al., 2006; Lin et al., 2001).
CGNs require depolarizing condition by culturing in specific extracellular concentration
of potassium which is approximately 25 mM (Balazs et al., 1988). The reduction from 25
mM K + to 5 mM K + leads to CGNs apoptosis (Balazs et al., 1988). This paradigm of
potassium deprivation is a well-charaxterized method to initiate and study survival
signaling and intrinsic apoptosis Thus, CGNs are a good in vitro model system to study
multiple pathways of neuronal cell death in vito.
1.3.2. BV2 cells
Accumulating evidence has linked neuroinflammation to neurodegenerative
disorders. This molecular pathway has been investigated in order to identify novel
therapies for such degenerative disorders. Microglia are the principle immune cells of the
CNS, and they play a pivotal role in neuroinflammation. During the pathological
progression of a neurodegenerative disorder, inflammation occurs following microglial
activation (Cunningham, 2013). Henn et al. (2009) suggested the mouse BV2 cell line is
a suitable alternative model for primary microglia, in order to reduce the experimental
preparation time and animal use. Indeed, the similarity of inducing inflammation
mediators in both primary microglial and BV2 cells has been demonstrated previously
(Henn et al. 2009). BV2 cells have also been utilized in pharmacological studies. For
example, LPS is a recognition factor known to activate both microglia and BV2 cell lines
to induce neuroinflammmation (Fig. 1.8) (Onasanwo et al., 2016). To enhance
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understanding of this death pathway, stimulation of BV2 microglia cells with LPS was
investigated to study the anti-inflammatory effect of different compounds (Onasanwo et
al., 2016). Thus, BV2 cells are an appropriate in vitro model to study neuroinflmmation
and will be useful to identify novel compounds that are capable of inhibiting this
particular cell death pathway.
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Figure. 1.8. BV2 mouse microglial cell line a standard model to study inflammation.
A. BV-2 culture was treated with vehicle (control). B. BV-2 culture was treated with
lipopolysaccharide (LPS).
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CHAPTER TWO: NEUROPROTECTION COMPARISON OF CHLOROGENIC
ACID AND ITS METABOLITES AGAINST MECHANISTICALLY DISTINCT
CELL DEATH-INDUCING AGENTS IN CULTURED CEREBELLAR
GRANULE NEURONS AND BV2 CELL LINE.
2.1. Abstract
Although the number of patients diagnosed with neurodegenerative disorders like
Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease is increasing,
there are currently no effective treatments that significantly limit the neuronal cell death
underlying these diseases. Chlorogenic acid (CGA), a polyphenolic compound found in
high concentration in coffee, is known to possess antioxidant and free radical scavenging
activity. In this study, we investigated the neuroprotective effects of CGA and its major
metabolites in primary cultures of rat cerebellar granule neurons and BV2 the mouse
microglia cell line. We show that CGA and caffeic acid displayed a dramatic protective
effect against the nitric oxide donor, sodium nitroprusside. In marked contrast, ferulic
acid and quinic acid had no protective effect against this nitrosative stress. While CGA
and quinic acid had no protective effect against glutamate-induced cell death, caffeic acid
and ferulic acid significantly protected neurons from excitotoxicity. Finally, caffeic acid
was the only compound that displayed significant protective activity against hydrogen
peroxide, proteasome inhibition, caspase-dependent intrinsic apoptosis, and endoplasmic
reticulum stress in CGNs, and it protected BV2 cell from the inflammation induced by
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LPS. These results indicate that caffeic acid displays a much broader profile of
neuroprotection against a diverse range of stressors than its parent polyphenol, CGA, or
the other major metabolites, ferulic acid and quinic acid. We conclude that caffeic acid is
a promising candidate for testing in pre-clinical models of neurodegeneration.

2.2. Introduction
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease,
Huntington’s disease, and amyotrophic lateral sclerosis, are defined by the progression of
nervous system dysfunction attributed to multiple factors including but not limited to,
misfolding of proteins, mitochondrial dysfunction, excitotoxicity, and oxidative stress.
Therapeutic strategies that focus on these underlying factors are promising approaches
for the treatment of neurodegenerative diseases. Oxidative stress has been proposed as a
common pathological mechanism of essentially all major neurodegenerative diseases, and
typically results from excessive production of reactive oxygen species (ROS) consequent
to mitochondrial injury or dysfunction (Carrì et al, 2015; Moon and Paek, 2015;
Simoncini et al., 2015).
As a means of protecting against oxidative stress, cells are equipped with
free radical scavenging defenses that prevent accumulation of ROS. In addition to
enzymes that detoxify free radicals (e.g., superoxide dismutase and catalase), antioxidants
are chemical substances that either directly scavenge ROS or indirectly induce the
expression or activity of free radical scavenging systems that protect cells from oxidative
stress. Based on their neuroprotective effects, antioxidants have been suggested as a
viable approach to slow or halt the progression of neuronal cell loss in various
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neurodegenerative diseases. However, clinical trials with many common antioxidants
(e.g., vitamin E or vitamin C) have met with limited success, indicating that utilization of
additional antioxidants with diverse mechanisms of action, or targeted intracellular
delivery of these compounds (e.g., mitochondrial-targeted antioxidants), may be
necessary to reveal their full therapeutic potential (Polidori and Nelles 2014; Jin et al.
2014). Therefore, dietary intake of natural antioxidants that can directly scavenge free
radicals, as well as induce endogenous antioxidant defenses, may be one useful approach
to treat neurodegenerative diseases.
Polyphenols are an abundant class of micronutrients found in many plants
and are typically regarded as safe when taken as dietary supplements (e.g.,
epigallocatechin 3-gallate (EGCG) and resveratrol). They have the impressive ability to
scavenge ROS and reactive nitrogen species (e.g., nitric oxide). In addition, polyphenols
have been shown to modulate apoptosis, inflammation, ion channels, signal transduction,
and neurotransmitter release – all processes which are implicated in a number of
neurodegenerative diseases (Bhullar and Rupasinghe, 2013). Therapies that implement
dietary supplementation with these compounds have demonstrated their neuroprotective
potential (Bhullar and Rupasinghe, 2013; Bigford and Del Rossi, 2014; Daglia et al.,
2014; Virmani et al., 2013). Although polyphenols directly scavenge ROS and nitric
oxide, many studies have suggested that the antioxidant capacity of polyphenols is also
dependent on their indirect activation of pathways like nuclear factor E2-related factor 2
(Nrf2)/heme oxygenase-1 (Bhullar and Rupasinghe, 2013). Others have shown that
polyphenols inhibit many pathways that cause neuronal cell death through
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neuroinflammation, such as the nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB) and pro-inflammatory molecules like tumor necrosis factor alpha (TNF-α),
interferon gamma (IFN-γ), and interleukin (IL)-1𝛽, IL-6, IL-17A, IL-22. (Spencer et al.,
2012). Polyphenols can also upregulate free radical detoxifying enzymes, including
catalase, superoxide dismutase, and glutathione peroxidase (Bhullar and Rupasinghe,
2013). Finally, polyphenols have been shown to modulate the expression of pro-survival
and pro-apoptotic pathway components, such as Bcl-2 and Bax (Kelsey et al., 2010).
Coffee, the second most consumed drink in the world, has been shown to have
protective effects from diverse inflammatory diseases associated with oxidative stress
(Andersen et al., 2006). Coffee consists of many antioxidant compounds including its
main element caffeine, polyphenols like CGA, and volatile aromatic compounds
(Gonthier et al., 2003; Ludwig et al., 2014). Several studies have shown that oxidative
stress biomarkers are inversely correlated with the consumption of coffee (Hori et al.,
2014; Kempf et al., 2010; Yoshida et al., 2008). Furthermore, coffee consumption
enhances antioxidant capacity in vivo (Corrêa et al., 2012). In the context of
neurodegeneration, several studies have documented that coffee intake is associated with
a reduced risk of developing Parkinson’s disease (Ross et al., 2000; Sääksjärvi et al.,
2008; Costa et al., 2010).
Chlorogenic acid is a major polyphenolic component in many plants and is
abundant in coffee - particularly in green coffee beans that contain from 5% to 12% CGA
by weight (Farah and Donangelo 2006; Farah et al., 2008). It is an ester of transcinnamic acids (including caffeic acid, ferulic acid, p-coumaric acid) and quinic acid
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(Clifford, 1999). Chlorogenic acid has diverse health benefits such as cardioprotective
effects, lipid peroxidation inhibitory activity, anti-tumor effects, and antioxidant activity
(Namba and Matsuse 2002; Wan et al., 2013).
Caffeic acid is a derivative of CGA that also has antioxidant properties, a function
dependent on its chemical structure (Rice-Evans et al., 1996). The neuroprotective effects
of CGA and caffeic acid have been revealed through in vitro studies using rat brain,
where both polyphenolic compounds have been shown to inhibit acetylcholinesterase
activity and lipid peroxidation induced by various pro-oxidants, suggesting a possible
beneficial effect for Alzheimer’s disease (Oboh et al., 2013). Caffeic acid has also been
shown to reduce intracellular ROS produced by H2O2 and protects neuronal cells in vitro
from this oxidative insult (Jeong et al., 2011).
Ferulic acid, a component of green coffee beans and another metabolite of
CGA, has also been found to be an effective free radical scavenger. This antioxidant
action is related to its phenolic hydroxyl group that donates electrons in order to render
free radicals inert (Srinivasan et al., 2007). In addition to its intrinsic free radical
scavenging activity, in vivo studies have established that administration of ferulic acid
inhibits astrocyte activation induced by beta-amyloid peptide in mice (Cho et al., 2005).
The neuroprotective effects of quinic acid, another metabolite of CGA, have been
investigated through in vitro studies. Although not typically regarded as an antioxidant,
various chemical derivatives of quinic acid have been shown to inhibit the toxicity
induced by beta-amyloid peptide in PC12 cells (Hur et al., 2001).
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In order to investigate the neuroprotective effects of CGA and some of its
metabolites against a number of diverse mechanisms that contribute to neurodegenerative
diseases, we pre-incubated cerebellar granule neurons (CGNs) with CGA, caffeic acid,
ferulic acid, or quinic acid (Fig. 2.1), and then exposed them to different stressors that
result in neuronal cell death. Cell viability was measured by MTT assay,
immunocytochemistry was used to visualize the microtubule network, Hoechst stain was
used to visualize nuclear morphology, and nitrite level was assessed by the Griess assay.
The results demonstrate that CGA, caffeic acid, and ferulic acid each show some
neuroprotective effects; however, caffeic acid displays a much broader neuroprotective
profile against a diverse range of neurotoxic stressors than CGA or ferulic acid. Based on
its broad neuroprotective profile, caffeic acid is a viable therapeutic candidate for testing
in pre-clinical models of neurodegeneration.
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Figure 2.1. Structural comparison of chlorogenic acid, caffeic acid, ferulic acid, and
quinic acid
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2.3. Materials and methods
2.3.1. Materials.
Hoechst dye, monoclonal antibody to β-tubulin, paraformalde-hyde, glutamic
acid, and glycine were obtained from Sigma Aldrich (St. Louis, MO). Fluorescein
isothiocyanate (FITC)-conjugated secondary antibody for immunofluorescence was from
Jackson Immunoresearch Laboratories (West Grove, PA), 3-(4,5-dimethythiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) reagent was obtained from Life Technologies
(Grand Island, NY) and made up in 1X phosphate buffered saline (PBS, pH 7.4).
Brefeldin A was obtained from Cell Signaling (Danvers, MA). PS-341 was purchased
from Bio Vision (Mountain View, CA). Sodium nitroprusside (SNP) was obtained from
Calbiochem (San Diego, CA). Chlorogenic acid, caffeic acid, ferulic acid, and quinic
acid were obtained from Sigma Aldrich (St. Louis, MO). Caffeic acid was solubilized as
stock solutions in DMSO and other compounds were made in sterile water. Griess
reagent assay was obtained from Thermo Scientific (Waltham, MA). Lipopolysaccharide
obtained from Sigma Aldrich (St. Louis, MO). Stock solution of glutamate/glycine was
made in sterile water. Brefeldin A and PS-341 were solubilized as stock solutions in
DMSO.
2.3.2. Cell culture.
2.3.2.1. Cerebellar granule neurons (CGNs)
Cerebellar granule neurons (CGNs) were isolated from 7-day-old SpragueDawley rat pups (15-19g) of both sexes as described previously (Linseman et al., 2001).
Briefly, neurons were plated on poly-L-lysine-coated culture plates at a density of
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2.0x106 cells/ml in Basal Modified Eagle’s medium (BME) containing 10% fetal bovine
serum, 25 mM KCl, 2 mM L-glutamine, penicillin (100units/ml)-streptomycin
(100µg/ml) (Life Technologies, Inc., Gaithersburg, MD). Cytosine arabinoside (final
concentration of 10µM) was added after 24h to limit the growth of non-neuronal cells.
With this protocol, the purity of granule neurons was ~95-99%. After 6 or 7 days in
culture, CGNs were rinsed two times in serum-free culture medium containing 25mM
potassium (25K-Serum) and maintained in the same medium for pre-incubation with
either chlorogenic acid (10µM), caffeic acid (50µM), ferulic acid (50µM), or quinic acid
(10µM), individually for 24h. Apoptosis was induced either by removal of depolarizing
extracellular potassium (5mM KCl; 5K apoptotic condition), or by the direct addition of
the following stressors: (1) the nitric oxide donor, sodium nitroprusside (SNP; 50µM), (2)
100µM glutamate and 10µM glycine (Glu/Gly) to induce excitotoxicity, (3) hydrogen
peroxide (H2O2; 50µM), (4) the proteasome inhibitor PS-341 (100 µM), or (5) the
endoplasmic reticulum (ER)-Golgi transport inhibitor, Brefeldin A (15 µM). Pre-treated
cells were treated overnight for approximately 16-18h with each stressor.
2.3.2.2 BV2 cell line
BV-2 cells were seeded on uncoated culture plates and maintained in DMEM
supplemented with 10% fetal bovine serum, and penicillin (100units/ml)-streptomycin
(100µg/ml) at 37° C in 5 % CO2. Next day we removed 1 ml of the medium from each
well and pretreat cells with the same concentration from the four compounds that we used
with CGNs for 24h. Then we added LPS (1μg/ml) for an additional 17 h. After that we
measured nitrite production by the Griess assay.
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2.3.3. MTT assay.
After overnight incubation with the appropriate stressor, 100µl of MTT reagent
was added to each well followed by incubation at 37°C for an additional 4h. Two ml of
DMSO was added to each well to dissolve formazan crystals and the medium containing
the dissolved crystals was read immediately in a microplate reader (BIO-RAD microplate
reader-550) at 570 nm. A blank containing 25K-Ser medium, MTT reagent, and DMSO
was prepared in parallel, and incubated without cells. The data were plotted as the
percentage of cell viability relative to the control mean absorbance for each independent
experiment. A minimum of n=4 experiments with duplicate wells for each treatment
group were performed for each stressor.

2.3.4. Immunocytochemistry and fluorescence imaging.
CGNs were washed once in 1X PBS and then fixed with 4% paraformaldehyde
for 45min at room temperature. Cells were then blocked and made permeable at room
temperature for 1h using a solution of 5% BSA and 0.2% Triton X-100 in 1X PBS. Then
they were incubated with a primary antibody to β-tubulin in 2% BSA and 0.2% Triton X100 in 1X PBS, overnight at 4°C. The next day, cells were washed 5 times with 1X PBS
and then incubated for 1h at room temperature with FITC-conjugated secondary antibody
diluted 1:250 in 2% BSA and 0.2% Triton X-100 in1X-PBS. To stain the nuclei, Hoechst
staining (1:500) was added to the secondary antibody solution. The following day, cells
were washed 5 times with 1 X PBS, and anti-quench solution prepared from 1X PBS and
1-5 mg of p-phenylenediamine was added to the cells before imaging. Images were
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captured using a 40X objective on a Zeiss Axiovert-200M inverted fluorescence
microscope.
2.3.5. Nitrite Assay
After pretreated cells with the four compounds individually and add LPS, nitrite
level was assessed by the Griess assay. Sodium nitrite was used as standard to determine
nitrite concentration, and absorbance was measured at 550nm.

2.3.6. Statistical Analysis.
Experiments were performed using duplicate or triplicate wells for each treatment
condition. Graphic data represent the means±SEM for the number (n) of independent
experiments performed. Statistical analysis was performed using either one-way analysis
of variance (ANOVA) and a post hoc Tukey’s test or unpaired t test. Differences between
treatment groups were considered statistically significantly different at a value of p<0.05.

2.4. Results
2.4.1. CGA and caffeic acid protect CGNs from nitrosative stress induced by the nitric
oxide donor, sodium nitroprusside (SNP).
CGNs were pre-incubated with CGA (10µM), caffeic acid (50µM), ferulic acid
(50µM), or quinic acid (10µM) for 24h, and then treated in the presence or absence of
SNP (50µM) for an additional 16-18h. To assess neuronal injury induced by SNP in
CGNs, we first examined the integrity of the microtubule network and nuclear
morphology. Compared to control cells, SNP caused a dramatic disassembly of the
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microtubule network in CGNs as shown by immunostaining for β-tubulin (Fig. 2.2A).
CGA and caffeic acid each substantially protected the microtubule cytoskeleton from
damage induced by SNP. Nuclei were considered as apoptotic if fragmented or
condensed as assessed by Hoechst staining. De-colorized (black & white) Hoechst
staining images are shown in Fig. 2.2A and enlarged (2.5X) in Fig 2B to clearly show
differences in nuclear size and morphology. Control cells displayed large intact nuclei. In
contrast, SNP- treated CGNs showed very small and condensed nuclei (Fig 2.2B).
However, nuclear condensation was decreased markedly by pre-incubation with either
CGA or caffeic acid. Neither ferulic acid nor quinic acid had any effect on SNP-induced
nuclear condensation or microtubule disassembly. In agreement with these morphological
findings, quantitative measurement of cell viability by MTT assay confirmed that only
CGA and caffeic acid significantly protected CGNs from nitrosative stress induced by
SNP. The data from four independent experiments are shown in Fig. 2.2C as the
(means±SEM) percentage of viable CGNs relative to controls.
It should be noted that similar results were obtained when CGA and each of its
metabolites were used at equivalent (50μM) concentrations for pre-treatment of CGNs.
Because CGA and quinic acid each displayed a small amount of basal cytotoxicity at
50μM in CGNs, for all subsequent experiments we utilized these two compounds at a
concentration of 10μM. Regardless, for each stressor used, similar results were obtained
to those shown when CGA and its metabolites were each used at equivalent (50μM)
concentrations (data not shown).
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Figure 2.2. Chlorogenic acid and caffeic acid protect CGNs from nitrosative stress.
(A) CGNs were pre-incubated for 24h in serum-free culture medium containing
25mM KCl (Control; Con ) alone or with chlorogenic acid (CGA; 10μM), caffeic
acid (CA; 50μM), ferulic acid (FA; 50μM), or quinic acid (QA; 10μM). Cells were
then incubated for an additional 16-18h with the nitric oxide donor, sodium
nitroprusside (SNP; 50μM). Following incubation, CGNs were fixed and stained for
β-tubulin (FITC; green) and nuclei were visualized with Hoechst staining (blue). Decolorized (black & white) panels are shown to emphasize nuclear morphology. (B)
The areas demarcated by the boxes in (A) were magnified 2.5X to show differences
in nuclear size. (C) Quantification of cell viability following SNP exposure using an
MTT assay. Results are expressed as a % of Con viability (set to 100%) and are
shown as mean±SEM (n= 4 experiments performed in duplicate). ### p<0.001 vs.
Con; ***p<0. 001, **p<0.01 vs. SNP; as assessed by one-way ANOVA with a post
hoc Tukey’s test.
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2.4.2. Caffeic acid and ferulic acid protect CGNs from excitotoxicity induced by
glutamate/glycine.
Next, we used glutamate/glycine co-treatment to trigger Ca2 +-dependent
excitotoxicity in CGNs and investigate the protective effects of CGA and its metabolites.
CGNs were pre-incubated with each of the four compounds as indicated above and then
treated for a further 16-18h with glutamate/glycine (final concentrations; 100µM/10µM).
The integrity of the microtubule network and nuclear morphology were assessed by
immunocytochemistry for β-tubulin and Hoechst staining, respectively. Compared with
untreated control cells, glutamate/glycine caused a marked disassembly of the
microtubule network in CGNs (Fig. 2.3A). Furthermore, nuclei were fragmented or
condensed following exposure to glutamate/glycine (Fig. 2.3A and enlarged 2.5X in Fig.
2.3B). Pre-incubation with either caffeic acid or ferulic acid significantly reduced
excitotoxic damage to the microtubule cytoskeleton and diminished the appearance of
apoptotic nuclei (Figs. 2.3A, 2.3B). In contrast, neither CGA nor quinic acid protected
CGNs from these morphological effects of excitotoxicity (data not shown). As an
additional measure of neuroprotection, cell viability was measured by MTT assay. The
data from four independent experiments are shown in Fig. 2.3C as the percentage of
viable CGNs relative to controls (means±SEM). Glutamate/glycine caused a nearly 75%
reduction in CGN viability that was unaffected by pre-incubation with CGA. However,
caffeic acid and ferulic acid each provided significant protection from excitotoxicityinduced cell death. Cells treated with quinic acid trended towards increased viability but
the results did not reach statistical significance. These data show that only caffeic acid
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and ferulic acid are capable of protecting CGNs from glutamate/glycine-induced
excitotoxicity.
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Figure 2.3. Caffeic acid and ferulic acid protect CGNs from excitotoxicity induced
by glutamate/glycine. (A) CGNs were pre-incubated for 24h with CGA or its
metabolites as described in the legend to Figure 2A, and then exposed to
glutamate/glycine (100μM/10μM; final concentrations) for 16-18h. Cells were
stained for β-tubulin and nuclear morphology as described in Figure 2.2 (B) The
areas demarcated by the boxes in (A) were magnified 2.5X to show differences in
nuclear size. (C) Quantification of cell viability following glutamate/glycine (Glu/Gly
or G/G) exposure using an MTT assay. Results are expressed as a % of Con
viability (set to 100%) and are shown as mean±SEM (n= 4 experiments performed
in duplicate). ###p<0.001 vs. Con; *p<0.05 vs. Glu/Gly; as assessed by one-way
ANOVA with a post hoc Tukey’s test
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2.4.3 Caffeic acid uniquely protects CGNs from oxidative stress induced by hydrogen
peroxide.
Oxidative stress is a major factor underlying the neuronal cell death in diverse
neurodegenerative disorders. Common ROS that cause oxidative stress include
superoxide radical and hydrogen peroxide (H2O2). To examine the neuroprotective
effects of CGA and its metabolites against oxidative stress, CGNs were pre-incubated
with each of the four compounds as indicated above and then treated for a further 16-18h
with H2O2 (50µM). In contrast to untreated control cells, CGNs exposed to H2O2
displayed a notable alteration of the microtubule network, characterized primarily by a
loss of smaller interconnecting processes (Fig. 2.4A). In addition, cells treated with H2O2
demonstrated substantial nuclear condensation indicative of an apoptotic-like death (Figs.
2.4A, 2.4B). Both of these effects were largely prevented by pre-incubation with caffeic
acid. Consistent with these morphological findings, MTT assay results showed that only
caffeic acid provided significant protection of CGNs (Fig. 2.4C). Incubation with H2O2
decreased cell viability by approximately 80% while pre-incubation with caffeic acid
prevented this reduction. These data demonstrate that among the compounds tested,
caffeic acid uniquely and significantly protects CGNs from oxidative stress induced by
H2O2.
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Figure 2.4. Caffeic acid protects CGNs from the oxidative stress induced by
hydrogen peroxide. (A) CGNs were pre-incubated for 24h with CGA or its
metabolites as described in the legend to Figure 2.2A, and then exposed to H2O2
(50μM) for an additional 16-18h. Cells were stained for β-tubulin and nuclear
morphology as described in Figure 2.2. (B) The areas demarcated by the boxes in
(A) were magnified 2.5X to show differences in nuclear size. (C) Quantification of
cell viability following H2O2 exposure using an MTT assay. Results are expressed as
a % of Con viability (set to 100%) and are shown as mean± SEM (n= 4 experiments
performed in duplicate). ###p<0.001 vs. Con; **p<0.01 vs. H2O2; as assessed by oneway ANOVA with a post hoc Tukey’s test.
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2.4.4. Caffeic acid exclusively protects CGNs from an inhibitor of ER-Golgi transport,
proteasome inhibition, and caspase-dependent apoptosis.
Additional mechanisms leading to neuronal cell death, besides those discussed
above (nitrosative stress, excitotoxicity, and oxidative stress), include ER stress,
proteasome inhibition, and caspase-dependent apoptosis, amongst others. In the next
series of experiments, we evaluated the neuroprotective effects of CGA and its
metabolites against Brefeldin A, an inhibitor of ER-golgi transport, a proteasome
inhibitor (PS-341), and 5K-induced (caspase-dependent) CGN apoptosis. Brefeldin A
suppresses transport between the ER and Golgi, eliciting inositol 1, 4, 5 triphosphate
(IP3) receptor-dependent Ca2+ toxicity and caspase-9-mediated apoptosis in CGNs
(Brewster et al., 2006). Proteasome inhibition induces CGN apoptosis by causing an
accumulation of c-Jun and pro-apoptotic Bim (Butts et al., 2005). CGNs require a high
extracellular potassium-regulated depolarization stimulus for survival in culture, and
removal of this depolarization stimulus (by switching the culture medium from 25mM
KCl to 5mM KCl; 5K apoptotic condition) induces CGN apoptosis via the intrinsic or
mitochondrial apoptotic pathway (D’Mello et al., 1993; Watson et al., 1998; Linseman et
al., 2002). When CGN survival was assessed by MTT assay, each of these stressors
(Brefeldin A, PS-341, and 5K apoptotic medium) induced at least a 60% loss of cell
viability (Figs. 2.5A-C). In cells pre-incubated with CGA and its metabolites, only those
CGNs treated with caffeic acid displayed a significant enhancement of survival upon
exposure to each of these diverse stressors. Thus, caffeic acid exclusively protects CGNs
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from ER stress, proteasome inhibition, and caspase-dependent apoptosis, demonstrating
its broad neuroprotective profile in this cell system.
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Figure 2.5. Caffeic acid protects CGNs from toxicity induced by Brefeldin A, the
proteasome inhibitor PS-341, and the caspase-dependent apoptosis inducer, 5K
medium. CGNs were pre-incubated for 24h with CGA or its metabolites as
described in the legend to Figure 2.2A, and then exposed to Brefeldin A (Bref), PS341, or 5K apoptotic medium for an additional 16-18h. (A), (B), and (C)
Quantification of cell viability (MTT assay) following incubation with Bref, PS-341,
or 5K apoptotic medium, respectively. Results are expressed as a % of Con viability
(set to 100%) and are shown as mean±SEM (n=4-6 experiments performed in
duplicate). ###p<0.001, ##p<0.01 vs. Con; **p<0.01; *p<0.05 vs. Bref, PS-341, or
5K; as assessed by one-way ANOVA with a post hoc Tukey’s test
57

2.4.5. Caffeic acid protects BV2 from inflammation induced by lipopolysaccharide (LPS)
the inflammatory stimulator.
Inflammation is another mechanism implicated in neurodegenerative diseases
that been investigated in this study. BV2 the mouse microglia cell line has been used as a
model to study inflammation. Lipopolysaccharide (LPS) was added to enhance the
production of pro-inflammatory mediators, including nitric oxide (NO). BV2 were preincubated with CGA (10µM), caffeic acid (50µM), ferulic acid (50µM), or quinic acid
(10µM) for 24h, and then treated in the presence or absence of LPS (1µG) for an
additional 16-18h. On the next day, NO levels were masseur by Griess assay. Caffeic
acid decreased the level of NO induced by LPS. Hence, caffeic acid inhibits the
inflammatory effect of LPS with BV2 (Fig. 2.6).
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2.6. Caffeic acid protects BV2 from inflammation induced by lipopolysaccharide
(LPS) the inflammatory stimulator. Quantitative assessment of nitric oxide
production by untreated BV2 microglia, and microglia stimulated by LPS alone or
with chlorogenic acid (CGA; 10μM), caffeic acid (CA; 50μM), ferulic acid (FA;
50μM), or quinic acid (QA; 10μM) pre-incubated for 24h. Data are represented as
mean ± SEM (n= 3 experiments for nitric oxide assay). ###p<0.001 vs. Con; ***p<0.
001, **p<0.01 vs. LPS; as assessed by one-way ANOVA with a post hoc Tukey’s test.
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2.5. Discussion
Coffee contains multiple antioxidant compounds including the polyphenol CGA.
Coffee intake is associated with an enhanced antioxidant status and reduced risk of some
neurodegenerative disorders, suggesting that coffee constituents, like CGA, are
neuroprotective. In the current study, we compared the neuroprotective effects of CGA
and its major metabolites against diverse stressors in cultured rat CGNs, an established
model to study neuronal cell death (Maycotte et al., 2010), we also stimulated BV2
microglia cells with LPS to investigate the anti-inflammatory effects of these compounds
(Onasanwo et al., 2016). An investigation of seven different cell stressors demonstrated
that CGA and ferulic acid each protected from one stressor, nitric oxide and glutamate,
respectively. In contrast, caffeic acid showed a very broad range of neuroprotective
activity against multiple stressors (Fig. 2.7). Although some previous studies have
investigated the neuroprotective effects of CGA and its metabolites in vitro, this has not
previously been explored in a systematic manner within a common cell system. Here, we
systematically compared the neuroprotective effects of these compounds in primary
CGNs and BV2 cell line challenged with diverse neurotoxic stressors.
Similar to our results showing that CGA and caffeic acid each protect
CGNs against the nitric oxide donor SNP, these compounds have also been shown to
reduce lipid peroxidation induced by SNP in rat brain in vitro (Oboh et al., 2013). The
protective effects of CGA and caffeic acid against nitric oxide-induced neurotoxicity are
likely due to direct free radical scavenging and appear to be dependent on the presence of
a catechol moiety which is common to these two compounds (Fig. 6) (Kono et al., 1997).
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In the case of excitotoxicity induced by glutamate, caffeic acid and ferulic
acid each significantly preserved the viability of CGNs. These results are consistent with
a previous report indicating that caffeic acid protects primary cultures of rat cortical
neurons from the excitotoxic effects of glutamate (Koo et al., 2006). Also in the same
study, caffeic acid attenuated excessive calcium influx and reduced ROS generation
caused by glutamate. In a similar manner, ferulic acid administration to pregnant mice
protected the brains of the developing fetuses, possibly through the action of ferulic acid
acting as an NMDA receptor antagonist (Yu et al., 2006).
Similar to our results showing that caffeic acid protects CGNs from H2O2, preincubation with caffeic acid also protected PC12 cells from this oxidative stress (Pavlica
and Gebhardt, 2005). In addition, a study in rats showed that caffeic acid protects the
brain against H2O2 in vivo (Pereira et al., 2006). The present study also revealed the
unique protective effects of caffeic acid against CGN apoptosis induced by low
potassium medium. Although we have not investigated the mechanism of this antiapoptotic effect, it seems plausible that caffeic acid may modulate pro-apoptotic or prosurvival gene expression to suppress caspase activity in this neuronal system. For
example, caffeic acid has been shown to decrease neurotoxicity induced by amyloid beta
by modulating Akt signaling in HT22 mouse hippocampal cells (Huang et al., 2013).
Caffeic acid also attenuated cell death of CGNs induced by the ER stressor Brefeldin A.
On the other hand, one prior report showed that in SH-SY5Y neuroblastoma cells, caffeic
acid did not inhibit cell death induced by tunicamycin, another ER stressor that acts
through a distinct mechanism to that of Brefeldin A (Izuta et al., 2008). While Brefeldin
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A acts by inhibiting transport between the ER and Golgi apparatus, tunicamycin inhibits
protein glycosylation in the Golgi apparatus (Colanzi et al., 2013; Izuta et al., 2008).
Therefore, the differences in the protective action of caffeic acid against Brefeldin A and
tunicamycin likely reflects modulation of factors involved in ER-Golgi transport rather
than protein glycosylation. Finally, caffeic acid also protected CGNs from cell death
caused by the proteasome inhibitor PS-341. To our knowledge, there are no prior reports
of caffeic acid protecting neurons from proteasome inhibition. One potential mechanism
through which caffeic acid could mediate protection is by modulation of pro-apoptotic
protein, Bim. Chronic exposure of CGNs to proteasome inhibition is shown enhance
expression of Bim, inducing apoptosis (Butts et al., 2005). Caffeic acid is known to
activate Akt, a known inhibitor of Bim signaling, which may promote cellular survival
under conditions of proteasome inhibition (Huang et al., 2013).
Finally, caffeic acid protected BV-2 cell from the inflammation induced by LPS.
Our data are in agreement with those that found caffeic acid decreased NO production
induced by LPS in macrophage cells (Búfalo et al., 2013). That protection and inhibition
of NO accumulation may be related to caffeic acid ability to block different pathway
implicated in forming NO like NF-kB, and MAPK (Búfalo et al., 2013). Pretreating BV2 with other compounds did not present any suppression of NO induced by LPS. Our
data were in contract with Shen et al. In their study chlorogenic acid decrease NO
production that promote by LPS in microglia cells. That contrast may because we used
lower concentrations of chlorogenic acid than in the Shen et al. study
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In summary, based on our systematic comparison of the neuroprotective effects of
CGA and its major metabolites in a single cell system, primary CGNs, we conclude that
CGA protects only from nitrosative stress and ferulic acid protects only from glutamate
excitotoxicity. In contrast, caffeic acid displays a broad neuroprotective profile against
oxidative and nitrosative stress, excitotoxicity, intrinsic apoptosis, ER stress, proteasome
inhibition and inflammation (Fig. 2.7). These findings suggest that caffeic acid is a
promising candidate for pre-clinical testing in mouse models of neurodegeneration. In
this context, caffeic acid phenethyl ester (CAPE) has been shown to limit dopaminergic
neurodegeneration and dopamine loss in mouse and rat models of Parkinson’s disease,
and CAPE also extends survival in a mouse model of amyotrophic lateral sclerosis
(Fontanilla et al., 2011; Fontanilla et al., 2012; Barros et al., 2013). It is noteworthy that
CAPE is rapidly hydrolyzed in vivo and its major metabolite is caffeic acid (Celli et al.,
2007). These facts may warrant a comparison of CAPE and caffeic acid in pre-clinical
disease models.
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Figure 2.7. The neuroprotective effects of chlorogenic acid and its metabolites in
CGNs. The schematic shows the broad neuroprotective effect of caffeic acid against
oxidative and nitrosative stress, glutamate excitotoxicity, proteasome inhibition, ER
stress, caspase depended apoptosis, and inflammation. In contrast, CGA protects
only from nitrosative stress and ferulic acid protects only from glutamate
excitotoxicity. Quinic acid did not display any significant neuroprotective activity in
CGNs and is omitted from the figure.
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CHAPTER THREE: THE NEUROPROTECTIVE EFFECTS OF ROSMARINIC
AND CARNOSIC ACID ON PRIMARY CEREBELLAR GRANULE NEURONS
3.1. Abstract
Neurodegeneration in the brain is the main cause of many devastating diseases,
such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s diseases. All
of these diseases are characterized by the progressive loss of neurons in specific regions
of the brain and/or spinal cord through either apoptosis or necrosis. Oxidative and
nitrosative stress, along with excitotoxicity and caspase activation, have been implicated
as the major underlying causes of cell death. Nutraceutical products have recently been
shown to have neuroprotective effects in a variety of in vitro and in vivo disease models.
The two nutraceuticals under investigation in this study are rosmarinic and carnosic acid
both of which are found at substantial concentrations in rosemary. In this study, these
two compounds’ability to attenuate damage to cultured cerebellar granule neurons
(CGNs) was observed and recorded. Both rosmarinic and carnosic acid have been shown
to mitigate these effects and reduce cell death when nitrosative stress is induced.
Rosmarinic acid also notably protected neurons against glutamate-induced excitotoxicity.
Furthermore, carnosic acid has the unique ability to protect CGNs from caspasedependent intrinsic apoptosis induced by removal of serum and depolarizing extracellular
potassium in the cell culture medium (i.e., 5K apoptotic condition). We additionally
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revealed that carnosic acid protects CGNs from 5K conditions specifically by activating
the phosphoinositide 3-kinase (PI3K) pro-survival pathway. The aim of this study was to
test the neuroprotective effects of these two compounds against these various different
kinds of cell death in order to determine their usefulness in attenuating neurodegenerative
diseases.
3.2. Introduction
Neurodegenerative diseases, or diseases of the brain with marked neuronal death
and consequential loss of brain matter, are increasing in prevalence. Some of the most
common neurodegenerative diseases include amyotrophic lateral sclerosis (ALS),
Parkinson’s disease, and Alzheimer’s diseases. According to a study published by
Environmental Health Perspectives in 2005, 50 million Americans a year are affected by
a neurodegenerative disease (Brown et al., 2005). Because most neurodegenerative
diseases are primarily sporadic in nature, an effective method of treatment would be to
prevent or slow the dying of neurons in affected brain regions. Inflammation, misfolded
proteins, mitochondrial dysfunction, oxidative and nitrosative stress and excitotoxicity
are all thought to be major mechanisms in the pathology of various neurodegenerative
diseases. Thus, therapeutic agents that target multiple disease aspects may be the most
viable treatment options.
Since ancient times, plants have been used as natural treatments for acute and
chronic disorders (Ghaffari et al., 2014). Over the last few decades, natural compounds
which possess medical benefits (or nutraceuticals) have been proposed as promising
treatment options for many diseases due to their intrinsic antioxidant abilities in
scavenging reactive oxygen and reactive nitrogen species. The activities of many of these
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compounds have been extensively investigated both within in vitro and in vivo models
(Ghaffari et al., 2014). Manufactured or commercially synthesized drugs often have more
activity than natural compounds. However, natural compounds have long term benefits
and generally produce fewer side effects (Espin et al., 2007). Most of these nutraceuticals
are abundant in potent phenolic antioxidant compounds, like phenolic acids, flavonoids,
tannins, and lignans (Cai et al., 2004).
Rosemary is a shrub found originally in different Mediterranean countries, and
now it is found abundantly throughout the world. In addition to its common use as a spice
in food, rosemary has been used in alternative and complementary medicine due to its
antioxidant activity (Rašković at el., 2014). In folk medicines, rosemary has been used as
a therapy for different diseases including headaches, inflammatory diseases, and stomach
problems (Rašković at el., 2014). Rosemary has significant intrinsic antioxidant activity
which is due to its molecular constituents, such as carnosol, carnosic acid, ursolic acid,
rosmarinic acid, and caffeic acid.
Rosmarinic acid (Figure 3.1A) is a polyphenol derivative of caffeic acid which
has antioxidant capabilities (Bhatt et al., 2013). It is naturally present in a number of
plants traditionally used in folk medicinal practices such as Orthosiphon diffusus,
Orthosiphon staminus, Rosmarinus officinalis, Artemisia capillaris and Calendula
officinalis (Scarpati and Oriente, 1958). It possesses many biological properties including
antioxidant (Lee et al., 2008), anti-inflammatory (Erkan et al., 2008), anti-mutagenic
(McKay and Blumberg, 2006), anti-angiogenic (Huang and Zheng, 2006),
hepatoprotective, anti-neurodegenerative (Lee et al., 2008), and NF-κB down-regulating
(Osakabe et al., 2004). Moreover, rosmarinic acid has been demonstrated to protect
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dopaminergic neuronal cells by inhibiting nitric oxide (NO) production from activated
glial cells (Lo et al., 2002; Park et al., 2008).
Carnosic acid (Figure 3.1B) also possesses antioxidant activity that may be related
to its ability to up-regulate endogenous free radical scavenging enzymes via activation of
the Nrf2 transcriptional pathway (Satoh et al., 2008). In another study, carnosic acid
showed a neuroprotective effect in vitro in human, induced pluripotent stem cells
(hiPSC)-derived neurons and in vivo in a mouse model against cyanide-induced brain
damage (Zhang et al., 2015). It also has antimicrobial properties (Birtic et al., 2015). In
addition, both compounds have demonstrated neuroprotective effects in different
neurodegenerative diseases. Rosmarinic acid has been shown to attenuate motor neuron
death in a mouse model of familial ALS (Shimojo et al., 2010; Seo et al., 2015), and
carnosic acid has been shown to have similar effects in a mouse model of Alzheimer’s
disease (Azad et al., 2011).
The purpose of the present study was to directly compare the neuroprotective
effects of these two compounds against oxidative damage caused by nitrosative stress,
excitotoxicity, and caspase activation in a single cell model of primary rat cerebellar
granule neurons culture. Further, we have defined the signaling pathway that carnosic
acid activates under 5K apoptosis conditions which rescues neurons from caspase
activation. Apoptosis was measured morphologically by immunocytochemistry to
visualize the microtubule network and Hoechst staining to visualize nuclear size and
architecture. To investigate the pro-survival pathway that carnosic acid activates when
demonstrating its neuroprotective effects, we used several different inhibitors including
wortmannin to inhibit PI3K, PD98059 to block MEK/ERK, and AKT inhibitor to
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attenuate AKT pro-survival pathway signaling (Figure 3.2). Our data demonstrate that
these compounds show overlapping and unique neuroprotective effects against different
stressors that cause cell death. The unique neuroprotective mechanism of these two
polyphenols has direct implications for designing future preclinical studies to evaluate the
therapeutic potential of these compounds for neurodegenerative diseases.
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Image credit: http://www.health-ingredients.com/cosmetic-ingredients/rosemaryextract.html

Figure 3.1. Structural comparison of rosmarinic acid (A) and carnosic acid (B).
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Figure 3.2. Overview of the pro-survival pathways that carnosic acid may activate
when demonstrating its neuroprotective effects. Different inhibitors include
wortmannin to inhibit PI3K, PD98059 to block MEK/ERK, and AKT inhibitor to
inhibit AKT pro-survival pathway signaling.
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3.3. Materials and methods
3.3.1. CGN Culture
Cerebellar granule neurons (CGNs) were isolated as previously described
(Linseman et al., 2001) from seven day-old Sprague Dawley rat pups. Cells were plated
on poly-L-lysine coated six-well plates (35mm-diameter), with a density of
approximately 2x106 cells/well in Basal Medium Eagle’s supplemented with 25mM
potassium chloride, 2mM L-glutamate, 10% fetal bovine serum, and 2mM penicillinstreptomycin (100U/mL/100µg/mL). 10µM cytosine arabinoside was added to the culture
medium 24 hours after plating to inhibit the growth of non-neuronal cells. Cultures were
~95% pure for granule neurons. The resulting CGNs were then incubated at 37˚C in 10%
CO2 for six to seven days in culture prior to experimentation. All animal manipulations
were performed in accordance with and under approval of the University of Denver
Institutional Animal Care and Use Committee.

3.3.2. Reagents
Sodium nitroprusside (SNP) and PD98059 were obtained from Calbiochem (San
Diego, CA). Carnosic acid (4aR,10aS)-5, 6-Dihydroxy-1,1-dimethyl-7-propan-2-yl2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid) and rosmarinic acid ((R)-O(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl) lactic acid, 3,4-Dihydroxycinnamic
acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl) ethyl ester) were obtained from AG
Scientific (San Diego, CA). Glutamic acid was purchased from MP Biomedical (Santa
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Ana, CA). Glycine, Hoechst, and wortmannin were obtained from Sigma Aldrich (St.
Louis, MO). AKT inhibitor was purchased from Calbiochem (San Diego, CA).
3.3.3 Treatment protocols.
3.3.3.1. Protocol for Treatment with SNP/glutamate+glycine
CGNs were co-treated with either carnosic or rosmarinic acid with the stressors
SNP or glutamate-glycine (100μM/10μM), for 24 before fixation and Hoechst staining
for quantification of cell death. For all experiments, an untreated control and an SNP or
glutamate-glycine only control were used to compare cell death/protection. Prior to
treatment, cell medium was removed and replaced with serum-free medium containing 25
mM KCl to prevent any potential protective effects of the serum.
3.3.3.2. Protocol for Treatment with 5K
CGNs were co-treated with either carnosic or rosmarinic acid, and 5K medium.
Prior to treatment, cell culture medium was aspirated, and the cells were washed once
with 5K medium to remove any leftover serum. 5K medium contains of Basal Medium
Eagle’s supplemented with 25mM potassium chloride, 2mM L-glutamate, and 2mM
penicillin-streptomycin (100U/mL/100µg/mL). After the first wash with 5K, the medium
was removed and replaced with fresh 5K medium. Wells whose medium was never
replaced, and wells with only 5K medium were used as controls. In the remaining
experimental wells, the appropriate concentration of rosmarinic or carnosic acid was
added. The cells were left in an incubator at 37˚C for 24 hours before fixation and
staining with Hoechst for quantification of apoptosis.
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3.3.3.3 Protocol for treatment with inhibitors
CGNs were co-treated with varying concentrations of carnosic acid, and then
either 5K medium, or 5K plus 10µM PD-98059, 100nM wortmannin, or 10μM AKT
inhibitor. Cells whose medium was never replaced, and cells with only 5K were used as
controls. Cells containing 5K plus the wortmannin, PD-98059, and AKT inhibitor
without carnosic acid were also included as controls. Cells were treated and then left in
an incubator for 24 hours before fixation, Hoechst staining, and quantification were
carried out.
3.3.4. Fixation and Hoechst Staining
Following treatment, CGNs were washed once with phosphate buffered saline
(PBS; pH=7.4) and fixed for one hour at room temperature in 4% paraformaldehyde.
Cells were then washed again with PBS and stained with Hoechst (10µg/mL). After a
minimum of one hour, the cells were imaged using a Zeiss Axiovert-200M epifluorescence microscope. Five images were taken per well to assess apoptosis, with either
duplicate or triplicate wells per experiment. Cells were counted and scored as either
living or apoptotic based on nuclear morphology using images showing decolorized
Hoechst fluorescence. CGNs having condensed or fragmented nuclei were counted as
apoptotic.
3.3.5. Data Analysis
Each experiment was performed using either duplicate or triplicate wells for each
treatment, with each experiment being performed at least three times. Data were
represented as the means +/- SEM of the total number of experiments. Data was analyzed
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using a one-way ANOVA with a post hoc Tukey’s test. A p-value of <0.05 was
considered statistically significant.

3.4. Results
3.4.1 Carnosic acid and rosmarinic acids each protect CGNs from nitrosative stress
SNP, a nitric oxide donor, has been shown to induce nitrosative stress, causing
cell death through the formation of reactive nitrogen species (RNS) (Eu et al., 2000).
Here, the efficacy of rosmarinic acid and carnosic acids against nitrosative stress was
examined by assessing the extent to which these two compounds prevented cell death
when cells were exposed to SNP. Cells death was determined by examining nuclear
morphology, and the state of the neuronal processes under bright field imaging. It was
found that SNP was very toxic to CGNs, as observed through their condensed and
fragmented nuclei as compared to the nuclei of untreated control cells (Figure 3.2A). It is
also evident through the bright field images that the neuronal processes are essentially
destroyed by SNP. These effects were largely reduced by 50 µM rosmarinic acid, and to a
slightly lesser but still significant extent by 10 µM carnosic acid (Figure 3.3A).
Quantification of these results is shown in Figure 3.2B as the percentage of apoptotic
cells counted using decolorized Hoechst fluorescence (Figure 3.3B) to assess nuclear
morphology. By this method, it was found that rosmarinic acid significantly decreased
cell death at doses of 50µM and 100 μM. Carnosic acid demonstrated a more potent
protective effect, at dose of 10µM and 20µM. Moreover, at concentrations of over 20µM
and 100µM of carnosic acid and rosmarinic acid, respectively, the compounds were
somewhat toxic on their own to CGNs (data not shown).
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Figure 3.3. Rosmarinic acid and carnosic acid each protect CGNs from nitrosative
stress. (A) CGNs were co-incubated for 24h in serum-free culture medium
containing 25 mM KCl (Control; Con) alone, or with rosmarinic acid (ROS; 50 μM)
or carnosic acid (CAR; 10μM) and sodium nitroprusside (SNP; 100 μM), or SNP
alone. Following incubation, CGNs were fixed and stained with Hoechst staining to
visualize the nuclei. Decolorized (black & white) panels are shown to emphasize
nuclear morphology (DAPI), and gray panels show the bright field images of the
same fields. Scale bar indicates 10µm. (B) Quantitative assessment of cellular
apoptosis for CGNs in untreated controls, 100µM SNP, and 100µM SNP plus 50 or
100µM ROS, or 10 or 20 µM CAR. Cells were quantified by counting as either
living or apoptotic based on nuclear morphology, and the percent of cells showing
apoptotic nuclei (either condensed or fragmented morphology) was determined.
Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001 compared to
control, *** indicates p<0.001 compared to SNP alone as determined using one-way
ANOVA with a post hoc Tukey’s test.
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3.4.2. Rosmarinic acid protects uniquely CGNs against excitotoxicity.
Glutamate and its co-agonist glycine, when introduced to cells, are known
to cause excitotoxicity through an influx of calcium. The molecules bind to ionotropic
glutamate receptors, allowing extracellular calcium to enter and greatly depolarize the
cell. This increase in intracellular calcium can activate calpains, form reactive oxygen
species (ROS) and RNS, and more generally cause the neuron to fire more action
potentials, causing further depolarization and increased frequency of the aforementioned
issues with high concentrations of intracellular calcium (Arundine and Tymianski 2003).
Rosmarinic acid notably protected CGNs against the insult of glutamate-glycine
(100μM/10μM); however, carnosic acid appended to worse the effects of glutamatetoxicity (Figure 3.3). To assess the extent to which CGNs were damaged by the insult
with glutamate and glycine, the cells were imaged and quantified by looking at
decolorized Hoechst images for nuclei stability and integrity (Figure 3.4A). The
percentage of apoptotic cells was determined for each treatment and the quantitative
results are shown in Figure 3.4B. Rosmarinic acid significantly protected CGNs from
excitotoxicity at 20μM and 50μM concentrations. In contrast, carnosic acid at doses of
10μM and 20μM enhanced the CGNs cell death in the presence of glutamate, though this
effect did not reach statistical significance.
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Figure 3.4. Rosmarinic acid, but not carnosic acid, protects CGNs from
excitotoxicity. (A) CGNs were co-incubated for 24h in serum-free culture medium
containing 25 mM KCl (Control; Con) alone or with rosmarinic acid (ROS; 20 μM)
or carnosic acid (CAR; 10μM) and glutamate/glycine (G/G; 100μM/10μM final
concentrations), or G/G alone. Following incubation, CGNs were fixed and stained
with Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are
shown to emphasize nuclear morphology (DAPI), and the gray panels show the
bright field images of the same fields. Scale bar indicates 10µm. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, G/G
(100μM/10μM) alone, and G/G plus 20 or 50 µM ROS, or 10 or 20 µM CAR. Cells
were quantified as either living or apoptotic based on nuclear morphology, and the
percent of cells showing apoptotic nuclei (either condensed or fragmented
morphology) was determined. Data are expressed as the mean +/- SEM, n=4. ###
indicates p<0.001 compared to control, *indicates p<0.05 compared to G/G alone as
determined using one-way ANOVA with a post hoc Tukey’s test.
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3.4.3. Carnosic acid uniquely protects CGNs against caspase activation
5K is a non-depolarizing, low potassium medium that causes caspase
activation in CGNs. Caspases cause what is known as programmed cell death when
activated. When the cell undergoes stress, such as the low potassium conditions seen with
this insult, pro-apoptotic proteins are ultimately activated. There are several pro-survival
cell signaling pathways that can be inactivated by 5K medium to allow caspase activation
and subsequent death of the cell. Stimulation of these pathways under 5K conditions can
therefore lead to cell survival and neuronal protection. The specific pathways we tested in
subsequent experiments were the pro-survival PI3K, MEK/ERK, and AKT pathways.
Carnosic acid significantly protected CGNs against 5K-induced apoptosis, whereas
rosmarinic did not (Figure 3.5). These results were again quantified from decolorized
Hoechst images (Figure 3.5B), and the percentage of apoptotic cells was determined.
Conversely to the results observed with glutamate, carnosic acid significantly protected
against the 5K insult at 10μM and 20μM. Additionally, 5K treatment alone damaged
processes to a lesser extent than either SNP or glutamate treatment (Figure 3.5A);
however, treatment with carnosic acid did improve the overall integrity of neuronal
processes. Rosmarinic acid offered no protect from 5K-induced apoptosis (Figure 3.5B)
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Figure 3.5. Carnosic acid, but not rosmarinic acid, protects CGNs from caspase
activation. (A) CGNs were co-incubated for 24h in serum-free culture medium
containing 25mM KCl (Control; Con). Treated cells had 25 mM KCl medium
replaced with a non-depolarizing, low potassium medium (5K medium) either alone
or with carnosic acid (CAR; 20 μM). Following incubation, CGNs were fixed and
stained with Hoechst (blue) and β-tubulin antibody (green) staining to visualize the
nuclei and tubulin respectively. Scale bar indicates 10µm. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, 5K, and 5K plus 20
or 50 µM ROS, or 10 or 20 µM CAR. Cells were quantified as either living or
apoptotic based on nuclear morphology, and the percent of cells showing apoptotic
nuclei (either condensed or fragmented morphology) was determined. Data are
expressed as the mean +/- SEM, n=4. ### indicates p<0.001 compared to control,
*** indicates p<0.001 compared to 5K media alone as determined using one-way
ANOVA with a post hoc Tukey’s test.
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3.4.4. Carnosic acid protects CGNs from 5K-induced apoptosis through PI3K activation,
but not AKT or MEK/ERK signaling.
Once it was determined that carnosic acid protected CGNs against 5K-induced
and caspase activation, we attempted to determine if these protective effects were due to
activation of specific pro-survival pathways that would inhibit caspase activation. First,
the PI3K pathway was investigated using wortmannin, a known PI3K inhibitor (Wymann
et al. 1996). It was determined that PI3K inhibition with wortmannin counteracted the
protective effects of carnosic acid (Figure 3.6). Decolorized Hoechst images for this
experiment are shown in Figure 6A, and were quantified to determine the percentage of
apoptotic cells (Figure 3.6B). The results showed that cells containing 5K medium,
carnosic acid, and wortmannin looked like the cells containing 5K medium alone. Thus
wortmannin effectively reversed the protective effect of carnosic acid seen under 5K
apoptosis conditions (Figure 3.6B). These findings demonstrated that the protective
effects of carnosic acid against 5K-induced apoptosis are PI3K dependent.
The next pathway investigated was the AKT pro-survival pathway, one of the
pathways activated downstream of PI3K. We blocked this pathway by using an AKT
inhibitor. The protective effect of carnosic acid was sustained even in the presence of the
AKT inhibitor. Decolorized Hoechst images for this experiment are shown in Figure 7A
and were quantified to determine the percentage of apoptotic cells (Figure 3.7B). The
results demonstrate that carnosic acid protects CGNs from 5K-induced apoptosis
independently of the AKT pro-survival pathway.
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Figure 3.6. Carnosic acid protects CGNs from caspase activation through the PI3K
pro-survival pathway. (A) CGNs were co-incubated for 24h in serum-free culture
medium containing 25 mM KCl (Control; Con). Treated cells had 25K mM KCl
medium replaced with a non-depolarizing, low potassium medium (5K medium)
either alone, with carnosic acid (CAR; 20 μM), with wortmannin (Wort; 100 nM),
or with Wort and CAR. Following incubation, CGNs were fixed and stained with
Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are
shown to emphasize nuclear morphology (DAPI), and the gray panels show the
bright field images of the same fields. Scale bar indicates 10µm. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus Wort,
5K plus 20 μM CAR, and 5K plus Wort and 20 μM CAR. Cells were quantified by
counting as either living or apoptotic based on nuclear morphology, and the percent
of cells showing apoptotic nuclei (either condensed or fragmented morphology) was
determined. Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001
compared to control, *** indicates p<0.001 compared to 5K media alone as
determined using one-way ANOVA with a post hoc Tukey’s test.
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Finally, we investigated the MEK/ERK pathway by using PD98059, a known
MEK/ERK inhibitor that works through binding to inactive MEK-1 and prevents
subsequent downstream activation of pro-survival ERK signaling (Crews et al., 1992).
Carnosic acid significantly protected CGNs from 5K-induced apoptosis even in the
presence of PD98059 (Figure 3.8A, 3.8B). This suggests that carnosic acid prevents
caspase activation through a mechanism independent of MEK/ERK signaling.
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Figure 3.7. Carnosic acid protects CGNs from caspase activation independently of
the AKT pro-survival pathway. (A) CGNs were co-incubated for 24h in serum-free
culture medium containing 25mM KCl (Control; Con). Treated cells had 25 mM
KCl medium replaced with a non-depolarizing, low potassium medium (5K
medium) either alone, with carnosic acid (CAR; 15 μM), with AKT inhibitor (AKT
inh; 10 μM), or AKT inh and CAR. Following incubation, CGNs were fixed and
stained with Hoechst (blue) and β-tubulin antibody (green) staining to visualize the
nuclei and tubulin, respectively. Scale bar indicates 10µm. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus AKT
inh, 5K plus 15 μM CAR, and 5K plus AKT inh and 15 μM CAR. Cells were
quantified by counting as either living or apoptotic based on nuclear morphology,
and the percent of cells showing apoptotic nuclei (either condensed or fragmented
morphology) was determined. Data are expressed as the mean +/- SEM, n=4. ###
indicates p<0.001 compared to control, *** indicates p<0.001 compared to 5K media
alone as determined using one-way ANOVA with a post hoc Tukey’s test.
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Figure 3.8. Carnosic acid protects CGNs from caspase activation independently of
the MEK/ERK pro-survival pathway. (A) CGNs were co-incubated for 24h in
serum-free culture medium containing 25mM KCl (Control; Con). Treated cells had
25 mM KCl medium replaced with a non-depolarizing, low potassium medium (5K
medium) either alone, with carnosic acid (CAR; 10 μM), with PD98059 (PD; 10
μM), or PD and CAR. Following incubation, CGNs were fixed and stained with
Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are
shown to emphasize nuclear morphology (DAPI), and the gray panels show the
bright field images of the same fields. Scale bar indicates 10µm. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus PD, 5K
plus 10 μM CAR, and 5K plus PD and 10 μM CAR. Cells were quantified by
counting as either living or apoptotic based on nuclear morphology, and the percent
of cells showing apoptotic nuclei (either condensed or fragmented morphology) was
determined. Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001
compared to control, *** indicates p<0.001 compared to 5K media alone as
determined using one-way ANOVA with a post hoc Tukey’s test.
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3.4. Discussion
Rosmarinic acid and carnosic acid have many bioactivities, including acting as
antioxidants, that may make them viable therapeutic options to diminish the underlying
pathophysiology of various neurodegeneration diseases. In the current study, we
compared the neuroprotective effects of rosmarinic acid and carnosic acid against
different stressors in cultured rat CGNs, a well-established in vitro model to examine
neuronal cell death (Maycotte et al., 2010). Moreover, we studied diverse mechanisms
that may underlie the protective effects of carnosic acid against intrinsic apoptosis.
Our data show that both rosmarinic acid and carnosic acid protected neurons from
an in vitro model of nitrosative stress induced by sodium nitroprusside (SNP). This
compound is a nitric oxide (NO) donor which can form highly toxic reactive nitrogen
species (RNS) such as peroxynitrite (Tsang and Chung 2009). When these toxic RNS
form, they cause extensive cellular damage, often resulting in death (Tsang and Chung
2009). The neuroprotective effects of rosmarinic acid are potentially linked to its abilities
to down regulate NF-ĸB and inhibit NO production from activated glial cells (Osakabe et
al., 2004; Lo et al., 2002; Park et al., 2008). However, rosmarinic acid may also directly
scavenge RNS like NO. Moreover, both compounds share a common catechol moiety
that acts as a hydrogen donor to free radicals and uses oxygen as an electron acceptor
(Oliveira et al., 2011). Furthermore, rosmarinic acid has previously been shown to have
both anti-inflammatory and antioxidant effects, and to attenuate motor neuron death in a
familial mouse model of ALS (Petersen and Simmonds 2003; Shimojo et al., 2010). Our
results are consistent with a previous study, in which rosmarinic acid inhibited NO
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production in RAW2647 mouse macrophages (Huang et al., 2009). Carnosic acid has
also been shown to effects of NO level that was induced by LPS in microglial cells
(Yanagitai et al., 2012). Thus, both rosmarinic acid and carnosic acid appear to mitigate
nitrosative stress via two mechanisms. First, these compounds blunt NO production from
macrophages and microglia. Second, they can act as direct scavengers of RNS like NO.
To understand the capacity of these compounds to mitigate different death
pathways that are involved in neurodegenerative diseases, we investigated their
protective effects in other models of neuronal cell death. Excitotoxicity has been shown
to play a role in these diseases, and therefore was tested with these agents to determine
their neuroprotective effects (Meredith et al., 2009). To replicate excitotoxicity in vitro,
CGNs were exposed to glutamate and glycine. When NMDA are receptors are activated
by phosphate and open, these calcium channels are over stimulated. Neuronal nitric oxide
synthase (nNOS) is subsequently activated and produces NO, and nitrosative and
oxidative stress effects can be observed, in addition to calcium overload and calpain
activation (Tsang and Chung 2009). We found that rosmarinic acid showed significant
protection against this particular type of cell death. Carnosic acid conversely enhanced
cell death caused by excitotoxicity. The opposite effects of these compounds on
excitotoxic cell death are striking and are not readily explained. Additional studies are
necessary to define the mechanisms underlying these results. Rosmarinic acid showed a
significant and unique neuroprotective effect against excitotoxicity, which has been
substantiated in another study performed in human neuroblastoma cells (Fallarini et al.,
2009).
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Our study found that carnosic acid specifically worsened the effects of
excitotoxicity in CGNs, while other studies have found it to antagonize intracellular
calcium mobilization in leukocytes (Poeckel et al., 2008). Another study suggested that
carnosic acid has anti-excitotoxic effects in vivo and in vitro neuronal models (e.g., HT22
hippocampal cells) (Satoh et al., 2008). The conflicting finding between our study and
these prior reports may be due to the different cell types utilized. Regardless of these
effects, carnosic acid protected CGNs against 5K apoptosis conditions, whereas
rosmarinic acid did not. This protocol subjects the cells to low potassium conditions,
subsequently causing caspase activation independent of nitrosative or oxidative stress,
resulting in programmed cell death (PCD) or intrinsic apoptosis.
To further characterize how carnosic acid protected against this specific type
of cell death, different inhibitors were used to test the involvement of specific cell
survival pathways. One of the pathways examined was the PI3K pro-survival pathway,
which was inhibited by wortmannin. Wortmannin suppressed the protective effects of
carnosic acid seen in 5K medium, suggesting that the neuroprotective effects of this
compound are dependent upon activation of the PI3K signaling pathway. A previous
study reported that pretreating IMR-32 cells with wortmannin decreases Nrf2 nuclear
translocation (Lee et al., 2001). Based on this result, the authors proposed that Nrf2 is
activated downstream of PI3K. Satoh et al. have reported that carnosic acid activates
Nrf2 in vivo and in vitro, and activates the transcriptional antioxidant response element
(ARE) of phase-2 genes that modulate the cellular redox state (Satoh et al., 2008, Satoh et
al., 2008b). Thus, the dependence of carnosic acid in neuroprotection against 5K88

apoptosis in CGNs on PI3K may involve subsequent activation of Nrf2. However, this
result seems somewhat unlikely, since 5K-induced apoptosis in CGNs occurs largely
independent of oxidative stress.
We also examined the AKT pathway, another pro-survival signaling pathway that
commonly act downstream of PI3K. To block this pathway, we added an AKT inhibitor
to CGNs along with carnosic acid and 5K media. Carnosic acid protected against 5Kinduced apoptosis even in the presence of the AKT inhibitor, suggesting that the PI3Kdependence of carnosic acid neuroprotection is not due to activing AKT.
The effects of MEK/ERK were then investigated using PD98059. This
compound is a MEK/ERK inhibitor, another cell signaling pathway involved in cell
survival. MEK/ERK can be activated downstream of PI3K activation of Ras. However,
carnosic acid protected against 5K medium even in the presences of PD98059. This result
showed that carnosic acid protects from apoptosis independently of the MER/ERK prosurvival pathway.
Since we have tested two pro-survival cell signaling pathways activated
downstream of PI3K (AKT and MEK/ERK), and neither was implicated in the protective
effect of carnosic acid, this indicate that, carnosic acid protects CGNs through another
PI3K-dependent pathway (Nakaso et al., 2003). One of these other PI3K-dependent
pathways could potentially be Nrf2 activation. Carnosic acid has been reported as an
activator of Nrf2. So we considered that carnosic acid could protect against caspase
activation by activation of PI3K, and subsequently Nrf2 activation. However, as
indicated above, this seems unlikely since CGN apoptosis induced by 5K does not have a
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significant oxidative stress component. Another possibility is a PI3K-dependent
activation of Ras GTPase and subsequent activation of P21-activated kinase (PAK)
(Marinissen and Gutkind 2001). Indeed, Ras and PAK signaling has been shown to be an
important pro-survival pathway for CGNs (Stankiewicz et al., 2015). Future studies will
examine if carnosic acid activates Rac/Pak in CGNs.
Rosmarinic acid has demonstrated neuroprotective effects in numerous
different studies, as well as it has been shown to protect against types of cell death not
examined in this study. For instance, other studies have shown rosmarinic acid to protect
against Aβ insults (commonly seen in Alzheimer’s disease) by mitigating similar types of
cell death as were examined in this paper (Iuvone et al. 2006). Aβ toxicity can cause cell
death through the generation of reactive oxygen species (ROS), lipid peroxidation, DNA
fragmentation and caspase activation (Iuvone et al. 2006). Interestingly, we found that
rosmarinic acid did not protect from caspase activation induced by 5K medium. The
experiments completed in this study, as well as results from other studies, find rosmarinic
acid to be an effective neuroprotective agent, though the method by which it attenuates
certain types of cell death (e.g., Aβ-induced apoptosis) is still largely unknown. This is
the next step that should be investigated. If the method by which this compound protects
against cell death could be discovered, it could have vast implications for future
neurodegenerative disease therapies.
Carnosic acid has also been shown in multiple studies, through its electrophilic
properties, to activate the transcription factor Nrf2 (Satoh et al. 2008; Takahashi et al.
2009). Various NRF-2- specific enzymes, for example heme oxygenase-1 (HO-1), are
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antioxidant molecules that provide efficient cell protection through regulating the
intracellular redox state (Satoh et al. 2008). In this regard, the protective abilities seen by
carnosic acid could be in part due to its electrophilic capabilities, combined with its
antioxidant properties. This finding is interesting because it could have an impact on how
neuroprotective compounds are regarded in the future. If electrophilic molecules also
attenuate cell death as Satoh et al. 2008suggest, the research of neurodegenerative
diseases could be expanded and perhaps even shifted. If electrophiles prove to be more
effective at preventing cell death, there are potentially many more compounds that could
demonstrate such effects.
Rosmarinic and carnosic acid, when taken together, could have many important
and beneficial uses. Both compounds showed a protective effect against the NO donor
SNP. Rosmarinic acid uniquely protected CGNs from excitotoxicity, and carnosic acid
uniquely protected CGNs from intrinsic apoptosis induced by 5K medium. Both have
been shown to have impressive antioxidant and neuroprotective effects. These effects
nicely complement each other, and add a potential future combination therapy for
devastating, sporadic neurodegenerative diseases.
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CHAPTER FOUR: PQQ PROTECTS CGNS FROM OXIDATIVE STRESS
4.1. Abstract
Neurodegenerative disorders are devastating and fatal disorders of the nervous
system that remain a critical focus of scientific research today. The underlying etiological
features of neurodegenerative diseases consist of many mechanisms known to cause
neuronal death, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and
nitrosative stress. Pyrroloquinoline quinone (PQQ) is a polyphenolic compound that is
found in high concentrations in fermented soybeans, parsley, and green tea. Recently,
PQQ has received significant of attention as a protective compound given its antioxidant
and anti-inflammatory bioactivities. Moreover, PQQ has recently been tested in
Parkinson’s diseases models, where it was demonstrated to attenuate dopaminergic
neuronal cell death. In this study, we examined the neuroprotective effects of PQQ in
primary cultures of rat cerebellar granule neurons. We showed that PQQ displayed a
protective effect against hydrogen peroxide- and copper chloride-induced oxidative
stress. Conversely, we report that PQQ did not exhibit any protection against
excitotoxicity, nitrosative stress, and caspase-dependent intrinsic apoptosis in cultured
neurons. These data indicate that PQQ has a dramatic neuroprotective effect, which is
specific to oxidative stress. This is an important finding as oxidative stress believed to be
a common underlying factor of several neurodegenerative diseases. We conclude that
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PQQ is a promising candidate for testing in preclinical models of neurodegeneration and
may represent a novel therapy for the treatment of neurodegenerative disorders for which
oxidative stress has been implicated as a causative factor.

4.2. Introduction
Neurodegenerative is a term from two words; neuro referring to nerves cells and
degenerative referring to progressive damage of the function and structure of neurons.
Neurodegenerative diseases include Parkinson’s disease (PD), Alzheimer’s disease (AD),
and amyotrophic lateral sclerosis (ALS). Age associated with increased risk of
neurodegenerative diseases. These diseases have an average onset of 50-70 years (Martin,
1999). However, patients with the familial forms of neurodegenerative disorders may
suffer from a much earlier onset of diseases (Martin, 1999). In many cases patients
present with a sporadic form of the degenerative disorder with no known genetic
component (e.g 90-95% sporadic in ALS; Thomas and Beal, 2007; Ferraiuolo et al.,
2011; Anand et al., 2013). In both familial and sporadic disorders, neuronal cell death can
occur through several different pathways, including mitochondrial dysfunction, oxidative
stress, excitotoxicity, and/or misfolding of proteins (Ferraiuolo et al., 2011; Chakrabarti
and Mohanakumar et al, 2016). Because of the complexity of the mechanisms involved,
there is growing scientific interest in elucidating alternative approaches to cure these
diseases. For example, several plants and their derivatives have displayed a remarkable
ability to improve the health of patients who suffer from neurodegenerative diseases
(Howes et al., 2003). Recent research indicates that the health benefits conferred by plant
therapy may be related to the pharmacological activities of their constituents, such as
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antioxidant, anti-inflammatory, pro-survival signaling pathways (i.e., enhancement of the
Nrf2 and CREB; transcription factor NF-E2-related factor 2 (Nrf2) that regulates the
expression of antioxidant genes and also cAMP-response element binding protein
(CREB) the pro-survival protein) (Wu et al., 2010).
One of the most abundant types of molecules that is found in plants are
polyphenols. Polyphenols have received a lot of attention due to their bioavailability and
recent prospective studies which have shown their benefits in vitro and in vivo (Del Rio
D et al., 2010). For instance, polyphenols display anti-apoptotic, antioxidant and anticancer activities (Mercer et al., 2005; Ferguson et al., 2004). In addition, patients with
neurological disorders have demonstrated an increase in life span after following diet rich
in polyphenols. Further, long-term treatment with polyphenols delayed the symptoms of
aging related disorders like ALS (Xu et al., 2006). Since natural compounds have
different pharmacological properties and may be able to attenuate several common causes
of neuronal cell death, it is possible that consuming these compounds may represent a
strong potential therapy for neurodegenerative illness.
Pyrroloquinoline quinone (PQQ) is a polyphenolic compound which is
found naturally in many plants, but with particularly high concentrations in fermented
soybeans, parsley, and green tea (Kumazawa et al., 1995). Research has provided
considerable insight into the multiple pro-survival properties of PQQ, and the importance
of a PQQ-rich diet has been demonstrated in numerous studies. A PQQ-deprived diet
leads to many physiological problems, such as defects in growth, reproduction, and
immune system performance (Steinberg et al., 2003; Rucker et al., 2009).
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In addition to its physiological activities, PQQ has several biomedical
activities. For example, PQQ reduced the amount of damage in an animal model of
cardiac ischemia (Rucker et al., 2009). The neuroprotective effects of PQQ have also
been investigated in countless studies due to its implication in several pro-survival
pathways. Neuro-inflammation is one of the prominent mechanisms that is thought to
contribute to neurodegeneration. The anti-inflammatory effect of PQQ has been
investigated in vitro. Yang et al. (2014) showed that PQQ treatment inhibited the
production of many inflammatory mediators which were induced by LPS such as,
inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis
factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin 6 (IL-6). Moreover, PQQ
showed protective effects against oxidative stress, another molecular pathway that is
consistently implicated in the etiology of neurological disorders (Nunome et al., 2008).
This effect of PQQ may be related to its ability to act as a free radical scavenger or its
ability to enhance Nrf2, thereby upregulating antioxidant genes (Zhang et al., 2012;
Nunome et al., 2008). In addition, aggregation of β-amyloid (Aβ) is potentially one of the
critical causes of Alzheimer’s disease (AD), and has been alleviated by treatment with
PQQ (Zhang et al., 2009). Interestingly, PQQ can also induce mitochondrial biogenesis,
and diets lacking PQQ have been shown to decrease the number of mitochondria
(Chowanadisai et al., 2010). In models of PD and stroke, PQQ attenuated neuronal death
(Qin et al., 2015: Jensen et al., 1994).
The purpose of the present study is to investigate the neuroprotective
effect of PQQ against different insults which activate neuronal death pathways. We pre95

incubated cerebellar granule neurons (CGNs) with PQQ (Fig. 4.1), and subsequently
treated the neurons with different toxic insults. The percentage of apoptosis was
measured by immunocytochemistry designed to visualize the microtubule network and
nuclear morphology. Our data demonstrate that PQQ displays significant neuroprotective
effects against two different neuronal insults which induce cell death via oxidative stress.
Conversely, PQQ failed to protect against insults that cause nitrosative stress, apoptosis,
and excitotoxicity. Based on our findings, PQQ may be a promising therapy for
neurodegenerative disorders for which oxidative stress is a major factor underlying
disease etiology.
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Image credit:
https://www.researchgate.net/publication/264799310_Discovery_of_a_Eukaryoti
c_Pyrroloquinoline_Quinone

Figure 4.1. Structural comparison of pyrroloquinoline quinone (PQQ).
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4.3. Method
4.1. Materials.
Hoechst dye, paraformaldehyde, glutamic acid, and glycine were purchased from
Sigma Aldrich (St. Louis, MO). Sodium nitroprusside (SNP) was obtained from
Calbiochem (San Diego, CA). Stock solutions of glutamate/glycine were made in sterile
water. Pyrroloquinoline quinone (PQQ) and copper chloride (CuCl2) were obtained from
Sigma Aldrich (St. Louis, MO).

4.2. Cell culture.
Cerebellar granule neurons (CGNs) were isolated from 7-day-old SpragueDawley rat pups (15-19g) of both sexes as described previously (Linseman et al., 2001).
Briefly, neurons were plated on poly-L-lysine-coated culture dishes at a density of
2.0x106 cells/mL in Basal Modified Eagle’s medium (BME) containing 10% fetal bovine
serum, 25 mM potassium chloride (KCl), 2 mM L-glutamine, penicillin (100units/ml)streptomycin (100µg/ml; Life Technologies, Inc., Gaithersburg, MD). Cytosine
arabinoside (AraC, final concentration of 10µM) was added after 24h to limit the growth
of non-neuronal cells. With this protocol, the purity of cerebellar granule neurons was
~95-99%. After 6 or 7 days in culture, CGNs were rinsed two times in serum-free culture
medium containing 25mM depolarizing potassium (25K-Serum) and maintained in the
same medium for pre-incubation with pyrroloquinoline quinone (PQQ; 10 nM, 30nM,
100nM, 300nM, and 1 μ M) for 24h. Apoptosis was induced either by removal of
depolarizing extracellular potassium (5mM KCl; 5K apoptotic condition), or by the direct
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addition of the following stressors: (1) sodium nitroprusside (SNP; 50µM) to induce
nitrosative stress, (2) 100µM glutamate and 10µM glycine (Glu/Gly) to induce
excitotoxicity, (3) hydrogen peroxide (H2O2; 1mM), or (4) copper chloride (CuCl2)
(70µM). Pre-treated cells were treated overnight for approximately 16-18h with each
stressor.
4.3. Fixation and Hoechst Staining
Following treatment, CGNs were washed once with phosphate buffered saline
(PBS; pH=7.4) and fixed for one hour at room temperature in 4% paraformaldehyde.
Cells were washed again with PBS and Hoechst stained at a concentration of 10µg/ml.
After a minimum of one hour, cells were imaged using a Zeiss Axiovert-200M epifluorescence microscope. Five images were taken per well to assess apoptosis, with either
duplicate or triplicate wells per experiment. Cells were counted and scored as either
living or apoptotic based on nuclear morphology using images showing decolorized
Hoechst fluorescence. CGNs displaying condensed or fragmented nuclei were counted as
apoptotic.
4.4. Statistical Analysis.
Every experiment was performed using either duplicate or triplicate wells for each
treatment, with each experiment being performed at least three times. Data are
represented as the means +/- SEM of the total number of experiments. Data have
analyzed using a one-way ANOVA with a post hoc Tukey’s test. A p-value of <0.05 was
considered statistically significant.
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4.4. Result:
4.1. PQQ protects CGNs from oxidative stress induced by hydrogen peroxide.
Oxidative stress occurs as a consequence of an imbalance between free radical
and antioxidant molecules (Uttara et al., 2009), resulting in neuronal cell death.
Treatment with hydrogen peroxide (H2O2) is a common model to study oxidative stress
(Fatokun et al., 2007). To assess the neuroprotective effects conferred by PQQ, CGNs
were pre-incubated with different concentrations of PQQ (10 nM, 30nM, 100nM, 300nM,
and 1 μM) for 24h. Next, pre-treated CGNs were treated with or without H2O2 (1 mM)
for an additional 16-18h. To evaluate neuronal injury induced by H2O2 in CGNs, we first
examined the nuclear morphology. Compared to control cells, H2O2 caused dramatic
damage to nuclei. Nuclei were considered as apoptotic if fragmented or condensed as
assessed by Hoechst staining (Fig 4.2A left panels). It is also evident through the bright
field images that the neuronal processes were also destroyed by H2O2. Importantly, these
effects were largely reduced by PQQ in a concentration dependent manner.
Quantification of these data presented as the percentage of apoptotic cells counted using
decolorized Hoechst fluorescence (Fig. 4.2B) to assess nuclear morphology. By this
method, it was found that PQQ significantly decreased cell death in a dose-dependent
manner, particularly at a concentration of 100nM, 300nM, and 1μM. However, lower
concentration did not show significant protective effects.
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Figure 4.2. PQQ protects CGNs from oxidative stress induced by hydrogen
peroxide. (A) CGNs were pre-incubated for 24h in serum-free culture medium
containing 25mM KCl (Control; Con) alone or with one of five different
concentrations of PQQ (10nM, 30 nM, 100nM, 300nM, and 1 μM) individually.
Cells were then incubated for an additional 16-18h with hydrogen peroxide (H2O2; 1
mM). Following incubation, CGNs were fixed and Hoechst stained. (B) Quantitative
assessment of cellular apoptosis for CGNs in untreated controls, 1 mM H2O2
concentration, and 1mM H2O2 plus 10nM, 30 nM, 100nM, 300nM, or 1μM PQQ.
Cells were quantified by counting them as either living or apoptotic based on
nuclear morphology, and the percent of cells showing apoptotic nuclei (either
condensed or fragmented morphology) was determined. Data are expressed as the
mean +/- SEM, n=4. *** indicates p<0.001 compared to control, ### indicates
p<0.001 compared to H2O2 alone, and # indicates p<0.05 compared to H2O2 alone as
determined using one-way ANOVA with a post hoc Tukey’s test.
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4.2. PQQ protects CGNs from oxidative stress induced by copper chloride.
In addition to H2O2, we also tested the oxidative stressor, copper chloride
(CuCl2) (Hu et al., 2016). CGNs were pre-incubated with PQQ (100nM, 300nM, and 1
μM) and subsequently treated for a further 16-18h with CuCl2 (final concentration;
70µM). Nuclear morphology was assessed by Hoechst staining. Nuclei were fragmented
or condensed following exposure to CuCl2 (Fig. 4.3A). However, pre-incubation with
each concentration of PQQ significantly reduced oxidative damage and diminished the
appearance of apoptotic nuclei (Fig. 4.3A, left panels). These data show that PQQ is
capable of protecting CGNs from CuCl2-induced oxidative stress. The percentage of
apoptotic cells was determined for each treatment, and the quantitative results are shown
in Figure 3B. All doses of PQQ significantly protected against CuCl2.
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Figure 4.3. PQQ protects CGNs from oxidative stress induced by copper chloride.
(A) CGNs were pre-incubated for 24h in serum-free culture medium containing
25mM KCl (Control; Con) alone or with one of five different concentrations of PQQ
(10nM, 30 nM, 100nM, 300nM, or 1 μM). Cells were then incubated for an
additional 16-18h with copper chloride (CuCl2; 70 μM). Following incubation,
CGNs were fixed and Hoechst stained. (B) Quantitative assessment of cellular
apoptosis for CGNs in untreated controls, 70μM CuCl2, and 70μM CuCl2 plus
10nM, 30 nM, 100nM, 300nM, and 1 μM PQQ. Cells were quantified by counting
them as either living or apoptotic based on nuclear morphology, and the percent of
cells showing apoptotic nuclei (either condensed or fragmented morphology) was
determined. Data are expressed as the mean +/- SEM, n=4. *** indicates p<0.001
compared to control, ### indicates p<0.001 compared to CuCl2 alone, and #
indicates p<0.05 compared to CuCl2 alone as determined using one-way ANOVA
with a post hoc Tukey’s test.
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4.3. PQQ did not protect CGNs from excitotoxicity, nitrosative stress, or caspase
activation.
Next, we examined the neuroprotective effect of PQQ against other death
pathways induced by glutamine/glycine, sodium nitroprusside (SNP), and 5K medium.
Extracellular glutamate mediates excitotoxicity by allowing calcium to enter and
depolarize the cell. This prolonged increase in intracellular calcium leads to the formation
of ROS and in turn, neuronal death (Arundine and Tymianski 2003). To modulate the
previous death pathway, we added glutamine/glycine (100μM/10μM). We induced
nitrosative stress by adding SNP (50 μM), the nitric oxide donor. Moreover, we enhanced
caspase activation by modifying the potassium level in CGN medium. CGNs were preincubated with PQQ (1 μM) and then treated for a further 16-18h with glutamine/glycine
(100μM/10μM), SNP (50 μM), or exposure to 5K apoptotic medium consisting of low
potassium conditions (5K medium). Unexpectedly, pretreatment with PQQ (1 μM) did
not show any protection against the previous insults and stressors. The percentage of
apoptotic cells was determined for each treatment and analyzed in Fig 4.4.
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Figure 4.4. PQQ did not protect CGNs from excitotoxicity, nitrosative stress, or
caspase activation by glutamate/glycine, SNP, or 5K medium, respectively. CGNs
were pre-incubated for 24h in serum-free culture medium containing 25mM KCl
(Control; Con) alone or with one of five different concentrations of PQQ (10nM, 30
nM, 100nM, 300nM, or 1 μM). Cells were then incubated for an additional 16-18h
with glutamate/glycine (100μM/10μM), SNP (50 μ M), or the low potassium medium
was removed. Quantitative assessment of cellular apoptosis for CGNs in untreated
controls, glutamate/glycine, SNP and 5K medium, and glutamine/glycine, SNP and
5K medium plus 10nM, 30 nM, 100nM, 300nM, and 1 μM PQQ. Cells were
quantified by counting them as either living or apoptotic based on nuclear
morphology, and the percent of cells showing apoptotic nuclei (either condensed or
fragmented morphology) was determined. Data are expressed as the mean +/- SEM,
n=4. *** indicates p<0.001 compared to control, ### indicates p<0.001 compared to
glutamine/glycine, SNP and 5K medium alone, and # indicates p<0.05 compared to
glutamine/glycine, SNP and 5K medium alone as determined using one-way
ANOVA with a post hoc Tukey’s test.
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4.5. Discussion
PQQ has many pro-survival properties such as antioxidant, anti-cancer, and antiinflammatory activities. In addition, PQQ has a unique ability for inducing mitochondrial
biogenesis. In the present study, we assessed the neuroprotective effects of PQQ against
different molecular cell death pathways that we modulated by exposure to several
stressors in cultured rat CGNs, an established model to study neuronal cell death
(Maycotte et al., 2010). An examination of five different cell stressors revealed that PQQ
showed a significant protection against insults that are known to induce oxidative stress
(H2O2 and CuCl2). However, PQQ failed to protect CGNs from other mechanisms that
prompt neuronal death including nitrosative stress, excitotoxicity, and caspase activation.
Oxidative stress is one of the mechanisms that leads to neuronal death, disturbing the
balance between ROS (e.g., H2O2) and antioxidants, ultimately underlying biological
aging (Yang et al., 2015).
The neuroprotective effects of PQQ against H2O2 are hypothetically
interrelated with its ability to scavenge free radicals, in addition to its other properties,
such as upregulation of the pro-survival protein Bcl-2, which is known to prevent the
release of mitochondrial cytochrome c that promotes cell death (Yang et al., 2015). Our
findings are similar to Yang et al. (2015), who demonstrated that PQQ alleviated the
oxidative stress induced by H2O2 and that PQQ modulated mitochondria to protect cells
from death (Yang et al., 2015). Taken together, our present findings in conjunction with
previous studies, suggest that PQQ possesses a neuroprotective effect against oxidative
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stress and may represent a novel therapy for the treatment of neurodegenerative
disorders.
There is not a lot of research examining the effects of PQQ on CuCl2; however,
other studies have used another insult to induce oxidative stress which is 6hydroxydopamine (6-OHDA) (Nunome et al. 2008). Similar to our data utilizing another
oxidative stress promoter, PQQ protected cells from this oxidative stressor (Nunome et
al. 2008). The neuroprotective effects of PQQ against nitrosative stress induced by SNP,
the NO donor have been examined. Our data indicate that PQQ does not protect cells
from nitrosative stress. Currently, other studies corroborating our findings are lacking.
Since it has been confirmed that excitotoxicity plays an important role in
neurodegenerative disorders, we also examined the protective effects of PQQ against
insults known to induce excitotoxic neuronal cell death. To induce excitotoxicity, we
treated cells with glutamate/glycine following pretreatment of CGNs with PQQ.
However, treatment with PQQ did not show any protection. These data are in contrast
with a study by Aizenman et al., demonstrating that PQQ attenuates the activation of
NMDA receptor to mediate in excitotoxicity in both cortical neurons and astrocytes
(Aizenman et al., 1992). This difference in experimental results may be correlated to
using different cell types or to the higher concentration of glutamate/glycine used in their
study.
The anti-apoptotic properties of PQQ have also been demonstrated in a
study by Lu et al. (2015), demonstrating that pretreatment with PQQ in an intracerebral
hemorrhage rat model, decreased caspase activation. The authors also reported that PQQ
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protected rats from apoptosis by increasing the ratio of the pro-survival protein Bcl-2 to
the pro-apoptotic protein Bax.
As an additional stressor to evaluate the protective effects of PQQ, we
activated the intrinsic apoptotic pathway by treating with 5K apoptotic medium, leading
to potassium deprivation by removing the optimum level of potassium required by CGNs.
Under that condition of deprivation (5K medium), PQQ didn’t protect CGNs from
apoptosis. Thus, it appears that PQQ is specifically protective against oxidative stress in
CGNs.
On the whole, our data support the neuroprotective effect of PQQ against
two distinct inducers of oxidative stress. Nevertheless, PQQ did not show any
neuroprotection against other neuronal death pathways (i.e., nitrosative stress,
excitotoxicity, or intrinsic apoptosis). This finding provides substantial vision into PQQ
as a potential therapy for neurodegenerative disorders. After the successful result by
testing PQQ in pre-clinical disease models of Parkinson disease (Qin et al., 2015), it’s
noteworthy to consider PQQ as a novel therapeutic option to treat patients with
neurodegenerative diseases that may be caused by oxidative stress.
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CHAPTER FIVE: CONCLUSIONS AND FUTURE DIRECTIONS
Caffeic acid is a broad compound among chlorogenic acid and the two
other metabolites (Ferulic acid and quinic acid) that showed protection against
multiple insults and stressors in vitro. Results show promising therapeutic
possibilities and pre-clinical testing, as caffeic acid phenethyl ester (CAPE) has
been shown to delay and decrease the hallmark symptoms in mouse and rat
models of Parkinson’s disease (Fontanilla et al., 2011). CAPE also delays the
death in a mouse model of amyotrophic lateral sclerosis (Fontanilla et al., 2012).
Since CAPE hydrolyzes to caffeic acid, and is the principle CAPE metabolites,
further research on caffeic acid would give similar results as CAPE. Therefore, it
was decided to not invest in more studies with caffeic acid.
Rosmarinic acid and carnosic acid showed a significant protective
effect from nitrosative stress. Moreover, rosmarinc acid and carnosic acid
protected CGNs from excitotoxicity and caspase activation-induced apoptosis,
respectively. Furthermore, both compounds showed an increased survival in
different models of neurodegenerative diseases. Rosmarinic acid caused a
noticeable decrease in motor neuron death in a mouse model of ALS. Also,
carnosic acid extended the survival of an Alzheimer’s disease mouse model. We
believe that more investigation with other models would prove valuable to study.
Since both compounds protected CGNs through different pathways, further
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studies that look at the synergistic properties of the combined compounds may be
a promising therapy for neurodegenerative disorders.
PQQ protected CGNs from oxidative stress induced by two insults,
hydrogen peroxide and copper chloride, even with very low concentrations of
PQQ. These data are promising in vitro, and encourage further study into the
mechanisms by which PQQ protects CGNs from these two insults. The ability of
PQQ to induce mitochondrial biogenesis and also induce the nerve growth factor
(NGF) has been demonstrated by several studies. Our future studies will examine
the involvement of mitochondria biogenesis on the protective effects of PQQ by
inhibiting PGC-1α, a key transcriptional regulator of mitochondria biogenesis. We
also plan to investigate the protection mechanisms, and if they depend on PQQ
activity for promoting NGF expression. PQQ showed a significant improvement
in pre-clinical disease models of Parkinson diseases. Further pre-clinical studies
with another model of neurodegenerative diseases, such as ALS mice, would be
appropriate. Table 1 represents the summary for the data.
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Insults and Chlorogenic Caffeic Ferulic Quinic Rosmarinic Carnosic PQQ
stressors
acid
acid
acid
acid
acid
acid
SNP

+

+

-

-

H2O2

-

+

-

-

Glutamate/
Glycine

-

+

+

-

Brefeldin
A

-

+

-

-

PS-341

-

+

-

-

LPS

-

+

-

-

+

+

+

+

-

CuCl2

5K

-

-

+

-

+

-

Table 1
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APPENDIX A: ABBREVIATIONS
6-OHDA; 6-hydroxydopamine
AChE; acetylcholinesterase
AD; Alzheimer’s disease
ALS; amyotrophic lateral scelorosis
Bcl-2; B cell lymphoma protein 2
AMPA; α – Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ARE; Antioxidant Response Element
BChE; butyrylcholinesterase
Bcl-2; B-cell lymphoma 2
BME; Basal Modified Eagle’s medium
CA; caffeic acid
Ca2+; calcium
CAPE; caffeic acid phenethyl ester
CAR; Carnosic acid
CGA; chlororgenic acid
CGN; cerebellar granule neuron
CNS; central nervous system
COX-2; cloxygenase-2
CREB; cyclic AMP response element binding protein
DMSO; dimethylsulfoxide
EAAT2; excitatory amino acid transporter 2
EGCG; epigallocatechin 3-gallate
ER; Endoplasmic reticulum
ERAI; ER stress-activated indicator
FA; ferulic acid
FDA; Food and Drug Administration
FIM; Foundation for Innovation in Medicine
Glu/Gly; glutamate/glycine
GluRdelta2; excitatory amino acid receptor delta2
GPx1; glutathione peroxide 1
GST; glutathione S-transferase
h; hours
H2O2; hydrogen peroxide
hiPSC; human induced pluripotent stem cells
HIV; human immunodeficiency virus
HO-1; heme oxygenase-1
hRSV; human respiratory syncytial virus
Hsp70; heat shock protein
IFN-γ; interferon gamma
IL-1β; Interleukin 1 beta
IL-6; Interleukin 6
KCL; potassium chloride
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LPS; Lipopolysaccharide
MPTP; methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
NMDA; N-Methyl-D-aspartate
nNOS; neuronal NO synthase
NO; nitric oxide
NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells transcription factor
NQO1; NADH-quinone oxidoreductase 1
Nrf2; NF-E2-related factor-2
O2-; superoxide
PBS; phosphate buffered saline
PC12; rat pheochromocytoma adrenal medulla cell line
PCD; programmed cell death
PD; Parkinson’s disease
PGC-1 α; peroxisome proliferator-activated receptor-ɣ coactivator-1α
PI3K; phosphoinositide 3-kinase
PQQ; Pyrroloquinoline quinone
QA; quinic acid
RNS; reactive nitrogen species
ROS; reactive oxygen species
ROS; Rosmarinic acid
SNP; sodium nitroprusside
SOD1; super oxide dismutase 1
SOD2; super oxidative dismutase 2
TNFα; Tumor necrosis factor
TRAIL; TNF-related apoptosis-inducing ligand
UPR; unfolded protein response
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